Data / Research funding / Cancer
Cancer: 19,860 NIH awards ($26B) to 1,559 organizations
19,860 NIH awards ($26B) in the NIH spending category Cancer, to 1,559 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 19,860 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| COG NCTN Year 12 BIQSFP Progress Report | NIH | National Cancer Institute | 2021 to 2025 | $141,250,012 | April 11, 2014 | February 28, 2026 | HAWKINS, DOUGLAS S. | reporter.nih.gov |
| BLDG. 538- 1ST FLOOR REFURBISHMENT AND INFRASTRUCTURE | NIH | National Cancer Institute | 2021 to 2025 | $116,680,370 | September 2, 2016 | June 30, 2019 | CRAIG, ROBILLARD | reporter.nih.gov |
| Consortium for Advancing Management and Prevention of Cancer in People with HIV | NIH | National Cancer Institute | 2021 to 2025 | $106,635,299 | August 29, 2006 | August 31, 2030 | SPARANO, JOSEPH A. | reporter.nih.gov |
| ECOG-ACRIN NCORP Research Base | NIH | National Cancer Institute | 2021 to 2025 | $95,697,835 | August 1, 2014 | July 31, 2026 | WAGNER, LYNNE I. | reporter.nih.gov |
| CANCER THERAPY EVALUATION PROGRAM INFORMATICS & COMPUTER SUPPORT | NIH | National Cancer Institute | 2021 to 2025 | $86,933,457 | July 1, 2022 | June 30, 2026 | RAJU, SUDHIR | reporter.nih.gov |
| INFORMATION TECHNOLOGY AND INFORMATICS SUPPORT TO THE DIVISION OF CANCER PREVENTION. | NIH | National Cancer Institute | 2021 to 2025 | $78,822,914 | September 22, 2022 | September 21, 2026 | RILEY, THOMAS | reporter.nih.gov |
| TASK ORDER 4A SITE STUDY SETUP: CTSU IDIQ | NIH | National Cancer Institute | 2022 to 2025 | $77,467,748 | August 1, 2022 | July 31, 2026 | PATRICHUK, LUCILLE | reporter.nih.gov |
| Pediatric HIV/AIDS Cohort Study (PHACS) 2020 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $71,153,847 | September 18, 2020 | July 31, 2026 | WILLIAMS, PAIGE L | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $69,157,920 | January 20, 1997 | March 31, 2026 | VICKERS, SELWYN M | reporter.nih.gov |
| NCI Early Career Cancer Clinical Investigator Award | NIH | National Cancer Institute | 2021 to 2025 | $65,560,307 | March 10, 1997 | November 30, 2026 | EBERT, BENJAMIN LEVINE | reporter.nih.gov |
| Alliance for Clinical Trials in Oncology Operations Center - GY11 BIQSFP Funded Extension | NIH | National Cancer Institute | 2021 to 2025 | $65,300,792 | April 17, 2014 | February 28, 2026 | PIANTADOSI, STEVEN | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $59,316,664 | August 28, 1996 | June 30, 2026 | DRAETTA, GIULIO FRANCESCO | reporter.nih.gov |
| GY11 BIQSFP Supplement Request | NIH | National Cancer Institute | 2021 to 2025 | $57,110,172 | March 17, 2025 | February 28, 2026 | BLANKE, CHARLES D. | reporter.nih.gov |
| NRG Oncology NCORP Research Base-BIQSFP | NIH | National Cancer Institute | 2021 to 2025 | $54,340,726 | July 11, 2025 | July 31, 2026 | BRUNER, DEBORAH WATKINS | reporter.nih.gov |
| Alliance NCORP Research Base | NIH | National Cancer Institute | 2021 to 2025 | $50,260,118 | August 1, 2014 | July 31, 2026 | PASKETT, ELECTRA D. | reporter.nih.gov |
| Imaging and Radiation Oncology Core (IROC) Group | NIH | National Cancer Institute | 2021 to 2025 | $48,919,038 | May 26, 2014 | February 28, 2026 | KRY, STEPHEN F | reporter.nih.gov |
| Abramson Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $48,027,008 | January 15, 1997 | May 31, 2026 | VONDERHEIDE, ROBERT H. | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2022 to 2025 | $44,496,290 | January 1, 1997 | December 31, 2029 | LYNCH, THOMAS JAMES | reporter.nih.gov |
| OCTRI - Culturally sensitive model to improve cervical cancer screening uptake in Spanish-speaking and American Indian/Alaska Native communities | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $43,274,051 | September 2, 2017 | July 31, 2026 | MORRIS, CYNTHIA D | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $42,039,159 | August 5, 1999 | May 31, 2028 | ASHWORTH, ALAN | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $41,720,565 | June 1, 1997 | November 30, 2025 | FERRIS, ROBERT L. | reporter.nih.gov |
| Regional Oncology Research Center | NIH | National Cancer Institute | 2021 to 2025 | $40,980,320 | May 7, 1997 | May 31, 2027 | NELSON, WILLIAM GEORGE | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $39,144,749 | September 1, 1998 | August 31, 2027 | PARK, BEN HO | reporter.nih.gov |
| CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT-Moonshot Funding | NIH | National Cancer Institute | 2021 to 2025 | $38,115,589 | June 1, 2021 | May 31, 2026 | VALMONTE, CLAUDIA | reporter.nih.gov |
| University of Michigan Rogel Cancer Center Support Grant 2023-2028 | NIH | National Cancer Institute | 2021 to 2025 | $36,682,234 | June 1, 1997 | May 31, 2028 | FEARON, ERIC R. | reporter.nih.gov |
| Blood and Marrow Transplant Clinical Trials Network DCC- The Medical College of Wisconsin, Inc. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $36,418,175 | September 15, 2017 | August 31, 2031 | HAMADANI, MEHDI HUSSAIN | reporter.nih.gov |
| Cancer Center Support Grant (CCSG) | NIH | National Cancer Institute | 2021 to 2025 | $35,080,297 | April 1, 1997 | February 28, 2026 | ROBERTS, CHARLES | reporter.nih.gov |
| CLINICAL TRIALS MONITORING SERVICE_ Moonshot support | NIH | National Cancer Institute | 2022 to 2025 | $34,785,582 | May 1, 2022 | April 30, 2026 | ANDERSON, BARRY | reporter.nih.gov |
| The Early Detection Research Network: Data Management and Coordinating Center | NIH | National Cancer Institute | 2021 to 2025 | $34,727,768 | April 14, 2000 | July 31, 2027 | ZHENG, YINGYE | reporter.nih.gov |
| SWOG NCORP Research Base | NIH | National Cancer Institute | 2021 to 2025 | $34,321,697 | August 1, 2014 | July 31, 2026 | BLANKE, CHARLES D. | reporter.nih.gov |
| COG Biospecimen Bank to Support NCI NCTN (U24) | NIH | National Cancer Institute | 2021 to 2025 | $34,059,058 | April 22, 2015 | March 31, 2027 | RAMIREZ MILAN, NILSA DEL CARMEN | reporter.nih.gov |
| University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG) | NIH | National Cancer Institute | 2021 to 2025 | $34,050,628 | December 1, 1996 | November 30, 2026 | LERMAN, CARYN | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $32,609,322 | August 2, 2001 | June 30, 2027 | EBERLEIN, TIMOTHY J. | reporter.nih.gov |
| The Robert H. Lurie Comprehensive Cancer Center | NIH | National Cancer Institute | 2021 to 2025 | $32,389,955 | August 1, 1997 | July 31, 2030 | PLATANIAS, LEONIDAS C. | reporter.nih.gov |
| BIOMEDICAL COMPUTING SERVICES FOR NCI DCCPS | NIH | National Cancer Institute | 2021 to 2022 | $32,166,053 | July 3, 2020 | July 2, 2023 | RONEY, DAVID | reporter.nih.gov |
| Strengthening LMIC Institutional Capacity for Direct NIH Grant Administration through the East Africa Cancer Collaboration | NIH | National Cancer Institute | 2021 to 2025 | $31,846,494 | January 1, 1997 | December 31, 2029 | KASTAN, MICHAEL B | reporter.nih.gov |
| Children's Oncology Group | NIH | National Cancer Institute | 2023 to 2025 | $31,354,180 | March 1, 2023 | February 28, 2026 | ALONZO, TODD A | reporter.nih.gov |
| IPP - DRUG DEVELOPMENT SUPPORT FOR CTEP | NIH | National Cancer Institute | 2022 to 2025 | $31,120,905 | July 1, 2022 | June 30, 2026 | MILLER, LAUREN | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $30,765,999 | September 10, 1997 | July 31, 2027 | BYRD, JOHN C. | reporter.nih.gov |
| A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research | NIH | National Cancer Institute | 2021 to 2025 | $30,268,190 | March 1, 1998 | February 29, 2028 | SHAW, BRONWEN | reporter.nih.gov |
| URCC NCORP Research Base | NIH | National Cancer Institute | 2021 to 2025 | $29,808,213 | June 1, 2025 | July 31, 2026 | MUSTIAN, KAREN M. | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $29,642,385 | September 12, 1997 | November 30, 2025 | RATHMELL, WENDY KIMRYN | reporter.nih.gov |
| FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | NIH | National Cancer Institute | 2021 to 2025 | $29,487,084 | April 6, 2018 | September 15, 2026 | PORRAS, CAROLINA | reporter.nih.gov |
| Mayo Clinic Comprehensive Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $29,249,641 | April 25, 1997 | August 31, 2030 | WILLMAN, CHERYL LYNN | reporter.nih.gov |
| Comprehensive Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $29,187,201 | March 28, 1997 | March 31, 2027 | SLECKMAN, BARRY P | reporter.nih.gov |
| UniProt: A Protein Sequence and Function Resource for Biomedical Science | NIH | National Human Genome Research Institute | 2021 to 2025 | $29,053,046 | September 18, 2014 | May 31, 2027 | BATEMAN, ALEX | reporter.nih.gov |
| Case Comprehensive Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $28,812,474 | August 1, 1997 | March 31, 2030 | SCHWARTZ, GARY K | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $28,807,695 | December 1, 1996 | March 31, 2030 | TEITELL, MICHAEL A | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $28,048,179 | July 4, 1997 | June 30, 2030 | RUSTGI, ANIL K | reporter.nih.gov |
| UW Comprehensive Cancer Center Support | NIH | National Cancer Institute | 2021 to 2025 | $27,903,806 | April 25, 1997 | March 31, 2028 | CAPITINI, CHRISTIAN | reporter.nih.gov |
| Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant | NIH | National Cancer Institute | 2021 to 2025 | $27,607,459 | June 1, 2025 | July 31, 2026 | ROTH, MICHAEL E. | reporter.nih.gov |
| Childhood Cancer Survivorship Study | NIH | National Cancer Institute | 2021 to 2025 | $27,522,831 | July 20, 1993 | November 30, 2026 | ARMSTRONG, GREGORY | reporter.nih.gov |
| Baylor College of Medicine/Stanford University Clinical Genome Resource (CLINGEN) | NIH | National Human Genome Research Institute | 2021 to 2025 | $26,073,883 | September 12, 2017 | June 30, 2027 | PLON, SHARON E. | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $25,541,728 | July 1, 1997 | July 31, 2029 | WINER, ERIC P. | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $25,514,923 | May 9, 1997 | April 30, 2027 | ULRICH, CORNELIA M | reporter.nih.gov |
| Center for Chronic Disease Reduction and Equity Promotion Across Minnesota (C2DREAM) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $24,809,662 | September 24, 2021 | December 31, 2026 | ALLEN, MICHELE L | reporter.nih.gov |
| SEER CORE INFRASTRUCTURE SUPPORT | NIH | National Cancer Institute | 2021 to 2025 | $24,152,243 | May 1, 2018 | April 30, 2026 | LIN-GOMEZ, SCARLETT | reporter.nih.gov |
| TO PROVIDE SEQUENCING SERVICES USING WHOLE GENOME SEQUENCING (GERMLINE FFPE) FOR NCI (KLEIN) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $24,069,896 | September 27, 2023 | December 31, 2025 | DOHENY, KIM | reporter.nih.gov |
| AIDS and Cancer Specimen Resource (ACSR) | NIH | National Cancer Institute | 2021 to 2025 | $24,013,599 | September 23, 2013 | August 31, 2026 | BETHONY, JEFFREY MICHAEL | reporter.nih.gov |
| Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $23,837,604 | April 9, 2019 | September 30, 2026 | GANGE, STEPHEN J | reporter.nih.gov |
| Wake Forest NCORP Research Base | NIH | National Cancer Institute | 2021 to 2025 | $23,707,562 | August 1, 2014 | July 31, 2026 | LESSER, GLENN J | reporter.nih.gov |
| Evaluating unmet survivorship needs: a multilevel assessment for a broad care network | NIH | National Cancer Institute | 2021 to 2025 | $23,369,596 | June 16, 1997 | April 30, 2026 | JOHNSON, CANDACE S | reporter.nih.gov |
| University of Washington/Fred Hutch Center for AIDS Research | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $23,344,932 | March 1, 1997 | May 31, 2028 | CELUM, CONNIE L | reporter.nih.gov |
| SF Bay Area MACS/WIHS Combined Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $23,128,905 | April 1, 2019 | September 30, 2026 | TIEN, PHYLLIS C | reporter.nih.gov |
| CCSG - Administrative Supplement - ECIA | NIH | National Cancer Institute | 2021 to 2025 | $22,920,176 | September 1, 1997 | March 31, 2029 | ODUNSI, KUNLE | reporter.nih.gov |
| Environmental triggers of early-onset colorectal cancer: interactions between microplastics and pks+ E coli in early-life gut colonization | NIH | National Cancer Institute | 2021 to 2025 | $22,669,275 | August 1, 1997 | July 31, 2026 | TUVESON, DAVID A | reporter.nih.gov |
| MANUFACTURE OF CLINICAL GRADE EPSTEIN-BARR VIRUS VACCINE | NIH | National Cancer Institute | 2023 to 2025 | $22,579,077 | September 22, 2025 | September 21, 2027 | reporter.nih.gov | |
| NRG Oncology Biospecimen Bank | NIH | National Cancer Institute | 2021 to 2025 | $22,321,931 | April 22, 2015 | March 31, 2026 | SIMKO, JEFF P | reporter.nih.gov |
| CTSU CORE SUPPORT SERVICES AND THE CTSU ENTERPRISE OF SYSTEMS - TASK AREA II | NIH | National Cancer Institute | 2021 | $22,304,622 | August 31, 2020 | August 30, 2021 | MARTIER, KAREN | reporter.nih.gov |
| Los Angeles CRS for the MACS/WIHS Combined Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $22,107,486 | April 15, 2019 | September 30, 2026 | MIMIAGA, MATTHEW JAMES | reporter.nih.gov |
| Moffitt Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $22,007,955 | February 18, 1998 | January 31, 2027 | CLEVELAND, JOHN L. | reporter.nih.gov |
| SEER CORE INFRASTRUCTURE SUPPORT | NIH | National Cancer Institute | 2021 to 2025 | $21,999,241 | May 1, 2018 | April 30, 2026 | CRESS, ROSEMARY | reporter.nih.gov |
| University of Pittsburgh MACS/WIHS CCS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $21,988,029 | April 1, 2019 | September 30, 2026 | RINALDO, CHARLES R | reporter.nih.gov |
| Center for Research, Health and Society | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $21,943,481 | September 24, 2021 | June 30, 2027 | CORNELL, CAROL ELLEN | reporter.nih.gov |
| UT Southwestern Medical Center Simmons Comprehensive Cancer Center | NIH | National Cancer Institute | 2021 to 2025 | $21,900,548 | September 1, 2010 | July 31, 2026 | ARTEAGA, CARLOS L | reporter.nih.gov |
| UCCC P30 Supplement: Human Endogenous Retrovirus-H as a Target for Early-Onset Colorectal Cancer | NIH | National Cancer Institute | 2021 to 2025 | $21,851,455 | September 1, 2025 | August 31, 2026 | SCHULICK, RICHARD D | reporter.nih.gov |
| Kids First Pediatric Data Resource Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $21,614,897 | September 1, 2025 | August 31, 2026 | RESNICK, ADAM CAIN | reporter.nih.gov |
| SEER CORE INFRASTRUCTURE SUPPORT | NIH | National Cancer Institute | 2021 to 2025 | $21,591,937 | May 1, 2018 | April 30, 2026 | CHARLTON, MARY | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $21,571,641 | August 1, 1997 | November 30, 2027 | CARPTEN, JOHN D. | reporter.nih.gov |
| LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INSTITUTIONAL REVIEW BOARD (CIRB) | NIH | National Cancer Institute | 2021 to 2023 | $21,394,060 | September 1, 2019 | August 31, 2024 | VALMONTE, CLAUDINE | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $21,374,625 | June 1, 1998 | January 31, 2029 | MILLER, JEFFREY S. | reporter.nih.gov |
| Kansas IDeA Network of Biomedical Research Excellence 5 | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $21,278,824 | September 18, 2001 | April 30, 2029 | WRIGHT, DOUGLAS E | reporter.nih.gov |
| Stanford Cancer Institute | NIH | National Cancer Institute | 2021 to 2025 | $21,225,913 | June 4, 2007 | May 31, 2027 | ARTANDI, STEVEN E | reporter.nih.gov |
| University of Arizona Cancer Center - Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $21,155,920 | July 1, 1997 | July 31, 2027 | THEODORESCU, DAN | reporter.nih.gov |
| Administrative Supplement to Cancer Center Support Grant (CCSG) | NIH | National Cancer Institute | 2021 to 2025 | $21,104,098 | September 1, 2025 | August 31, 2026 | BOUTROS, PAUL CHRISTOPHER | reporter.nih.gov |
| Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $21,023,937 | April 1, 2019 | September 30, 2026 | SHARMA, ANJALI | reporter.nih.gov |
| SEER CORE INFRASTRUCTURE SUPPORT | NIH | National Cancer Institute | 2021 to 2025 | $21,012,540 | May 1, 2018 | April 30, 2026 | LIU, LIHUA | reporter.nih.gov |
| Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $21,007,836 | April 1, 2019 | September 30, 2026 | MARGOLICK, JOSEPH B. | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $20,980,807 | December 1, 1996 | February 28, 2029 | MAITRA, ANIRBAN | reporter.nih.gov |
| Nebraska Research Network in Functional Genomics | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $20,833,603 | September 30, 2001 | April 30, 2026 | SORGEN, PAUL L | reporter.nih.gov |
| ECOG-ACRIN Biospecimen Bank to Support NCTN | NIH | National Cancer Institute | 2021 to 2025 | $20,630,107 | April 29, 2015 | March 31, 2027 | JEWELL, SCOTT D | reporter.nih.gov |
| Specialized Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2024 | $20,560,271 | July 1, 1996 | April 30, 2026 | SIMEONE, DIANE M | reporter.nih.gov |
| West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $20,261,619 | September 30, 2001 | July 31, 2029 | JOSHI, TRUPTI | reporter.nih.gov |
| Northwestern CORE Clinical Research Site: Trans-omics for HIV/AIDS Research | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $19,790,656 | April 10, 2019 | September 30, 2026 | WOLINSKY, STEVEN M | reporter.nih.gov |
| Metro-Minnesota Community Oncology Research Consortium (MMCORC) | NIH | National Cancer Institute | 2021 to 2025 | $19,766,845 | August 1, 2014 | July 31, 2026 | JI, YAN | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $19,528,719 | June 1, 1997 | June 30, 2028 | STEIDL, ULRICH | reporter.nih.gov |
| North American AIDS Cohorts on Collaboration and Design (NAACCORD) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $19,377,019 | July 1, 2006 | April 30, 2027 | ALTHOFF, KERI NICOLE | reporter.nih.gov |
| Oklahoma IDeA Network of Biomedical Research Excellence | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $19,194,069 | September 6, 2001 | August 31, 2030 | LANG, MARK L | reporter.nih.gov |
| Baylor College of Medicine Cancer Center - Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $19,034,443 | July 1, 2007 | June 30, 2030 | REDDY, PAVAN | reporter.nih.gov |
| Expanding HOPE Liver Transplantation: Understanding Opportunistic Infection and Cancer Risk | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,807,472 | August 1, 2018 | August 31, 2030 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| Pediatric Brain Tumor Consortium A multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors | NIH | National Cancer Institute | 2021 to 2025 | $18,653,803 | April 1, 1999 | March 31, 2026 | ONAR-THOMAS, ARZU | reporter.nih.gov |
| STORAGE AND DISTRIBUTION OF CLINICAL AGENTS | NIH | National Cancer Institute | 2023 to 2025 | $18,271,500 | February 1, 2023 | January 31, 2026 | MAHZAD, MEHRINFAR | reporter.nih.gov |
| LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INDIVIDUAL REVIEW BOARD (CIRB) | NIH | National Cancer Institute | 2024 to 2025 | $18,014,450 | September 1, 2024 | August 31, 2026 | VALMONTE, CLAUDINE | reporter.nih.gov |
| Cancer Center Support Grant P30 | NIH | National Cancer Institute | 2021 to 2025 | $17,994,069 | July 1, 2002 | June 30, 2026 | LARA, PRIMO N. | reporter.nih.gov |
| Heartland Cancer Research NCORP | NIH | National Cancer Institute | 2021 to 2025 | $17,817,032 | August 1, 2014 | July 31, 2026 | FALLER, BRYAN | reporter.nih.gov |
| The Wake Forest Nonhuman Primate Radiation Survivor Cohort | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $17,517,826 | August 1, 2020 | July 31, 2027 | CLINE, J. MARK | reporter.nih.gov |
| Kaiser Permanente NCI National Community Oncology Research Program, NCORP | NIH | National Cancer Institute | 2021 to 2025 | $17,245,643 | August 1, 2014 | July 31, 2026 | SUGA, JENNIFER MARIE | reporter.nih.gov |
| The American Lung Association (ALA) Lung Health Cohort | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $17,159,433 | June 15, 2019 | June 30, 2026 | KALHAN, RAVI | reporter.nih.gov |
| East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional Consortium | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $17,134,028 | June 1, 2025 | June 30, 2026 | WOOLS-KALOUSTIAN, KARA KAY | reporter.nih.gov |
| PROJECT MANAGEMENT, TECHNICAL, COMPUTING, AND ADMINISTRATIVE SUPPORT SERVICES FOR THE DIVISION OF CANCER CONTROL AND POPULATION SCIENCES (DCCPS) | NIH | National Cancer Institute | 2021 to 2025 | $16,904,215 | May 1, 2023 | April 30, 2026 | LEAHY, ERIN | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $16,870,049 | August 4, 1997 | November 30, 2029 | DRAGNEV, KONSTANTIN H. | reporter.nih.gov |
| International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,840,939 | May 1, 2025 | April 30, 2027 | ROHNER, ELIANE | reporter.nih.gov |
| SEER Core Infrastructure Support | NIH | National Cancer Institute | 2021 to 2025 | $16,456,520 | May 1, 2018 | April 30, 2026 | MUELLER, LLOYD | reporter.nih.gov |
| Administrative Supplement: The ASCEND (Advancing Skills in Contracting and Execution for NIH-Designated Grants) Initiative | NIH | National Cancer Institute | 2021 to 2025 | $16,211,327 | April 7, 2009 | March 31, 2028 | RAMALINGAM, SURESH S | reporter.nih.gov |
| SEER*EDUCATE BASE AWARD | NIH | National Cancer Institute | 2022 to 2025 | $16,160,319 | September 17, 2024 | August 16, 2026 | SCHWARTZ, STEPHEN | reporter.nih.gov |
| Michigan Cancer Research Consortium NCORP | NIH | National Cancer Institute | 2021 to 2025 | $16,033,140 | August 1, 2014 | July 31, 2026 | AL BAGHDADI, TAREQ | reporter.nih.gov |
| SWOG Biospecimen Bank to Support NCI NCTN | NIH | National Cancer Institute | 2021 to 2025 | $16,003,256 | April 23, 2015 | March 31, 2027 | RAMIREZ MILAN, NILSA DEL CARMEN | reporter.nih.gov |
| Biology of the Hormonal Regulation of Cancer and Immuno Oncology Outcomes Research Proposal. | NIH | National Cancer Institute | 2021 to 2025 | $15,746,743 | August 1, 1997 | June 30, 2027 | COUSSENS, LISA M | reporter.nih.gov |
| MACS/WIHS Combined Cohort Study: Cook County Clinical Research Site (CC_CRS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $15,678,563 | April 1, 2019 | September 30, 2026 | FRENCH, AUDREY | reporter.nih.gov |
| Understanding Population Differences in Cancer: The MEC Study | NIH | National Cancer Institute | 2021 to 2025 | $15,674,930 | September 1, 2012 | August 31, 2027 | LE MARCHAND, LOIC | reporter.nih.gov |
| Pancreatitis-induced initiation of early onset pancreatic cancer | NIH | National Cancer Institute | 2021 to 2025 | $15,447,190 | February 1, 2025 | January 31, 2026 | SHAW, REUBEN | reporter.nih.gov |
| Translational Research in Cancer | NIH | National Cancer Institute | 2021 to 2025 | $15,323,389 | June 22, 1995 | May 31, 2029 | CHAPMAN, ANDREW | reporter.nih.gov |
| Life Course Cancer Epidemiology Cohort in Women | NIH | National Cancer Institute | 2021 to 2025 | $15,280,631 | June 1, 2013 | August 31, 2028 | ELIASSEN, A. HEATHER | reporter.nih.gov |
| Early Career Cancer Clinical Investigator Award (ECIA) | NIH | National Cancer Institute | 2021 to 2025 | $15,192,711 | September 26, 2005 | August 31, 2026 | SANCHEZ, YOLANDA | reporter.nih.gov |
| Upstate Carolina Consortium - Community Oncology Research Program | NIH | National Cancer Institute | 2021 to 2025 | $15,178,307 | May 23, 2025 | July 31, 2026 | CURTIS, AMARINTHIA E | reporter.nih.gov |
| Atlanta MACS/WIHS Combined Cohort Study Clinical Research Site | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $15,081,381 | April 1, 2019 | September 30, 2026 | LAHIRI, CECILE DELILLE | reporter.nih.gov |
| SEER CORE INFRASTRUCTURE SUPPORT | NIH | National Cancer Institute | 2021 to 2025 | $15,040,839 | May 1, 2018 | April 30, 2026 | WARD, KEVIN | reporter.nih.gov |
| The Alliance NCTN Biorepository and Biospecimen Resource | NIH | National Cancer Institute | 2021 to 2025 | $15,002,332 | May 19, 2015 | March 31, 2027 | WATSON, MARK A. | reporter.nih.gov |
| Consolidated Basic Cancer Research Program | NIH | National Cancer Institute | 2021 to 2025 | $14,936,465 | April 1, 1997 | February 28, 2026 | ALTIERI, DARIO C | reporter.nih.gov |
| Indiana University Melvin and Bren Simon Comprehensive Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $14,928,659 | September 22, 1999 | August 31, 2029 | LEE, KELVIN P. | reporter.nih.gov |
| Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,843,451 | August 20, 2021 | May 31, 2028 | NAJI, ALI | reporter.nih.gov |
| SEER CORE INFRASTRUCTURE SUPPORT | NIH | National Cancer Institute | 2021 to 2025 | $14,742,630 | May 1, 2018 | April 30, 2026 | DURBIN, ERIC | reporter.nih.gov |
| SEER CORE INFRASTRUCTURE SUPPORT | NIH | National Cancer Institute | 2021 to 2025 | $14,700,458 | May 1, 2018 | April 30, 2026 | WIGGINS, CHARLES | reporter.nih.gov |
| P30 Administrative Supplement for Early-Onset Cancer Research: Repurposing orphan drugs for early-onset endometrial cancer | NIH | National Cancer Institute | 2021 to 2025 | $14,689,665 | August 8, 1997 | November 30, 2026 | PASCHE, BORIS | reporter.nih.gov |
| The Tisch Cancer Institute - Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $14,629,412 | August 1, 2015 | July 31, 2030 | PARSONS, RAMON E | reporter.nih.gov |
| UAB-MISS MACS/WIHS Combined Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $14,601,685 | April 1, 2019 | September 30, 2026 | KEMPF, MIRJAM-COLETTE | reporter.nih.gov |
| The UCSC Genome Browser | NIH | National Human Genome Research Institute | 2022 to 2025 | $14,584,394 | July 12, 2001 | April 30, 2027 | HAEUSSLER, MAXIMILIAN | reporter.nih.gov |
| Tracking and Engaging Disconnected Long-Term Survivors of Childhood Cancer to Improve Adherence to Evidence-Based Screening Guidelines | NIH | National Cancer Institute | 2021 to 2025 | $14,573,097 | September 5, 1997 | August 31, 2026 | SWEASY, JOANN B. | reporter.nih.gov |
| Neighborhoods, Stress and Cancer Outcomes Across the Cancer Control Continuum: Leveraging ecological theory and geospatial analytics to improve cancer prevention and outcomes (Project LEGO) | NIH | National Cancer Institute | 2021 to 2025 | $14,533,475 | August 8, 2008 | August 31, 2027 | OWONIKOKO, TAOFEEK K | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $14,418,205 | July 14, 2000 | March 31, 2027 | BURKARD, MARK E | reporter.nih.gov |
| Surviving the HIV Epidemic (S/HE) in metropolitan Washington DC - Advancing knowledge through cohort studies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $14,413,637 | April 1, 2019 | September 30, 2026 | KASSAYE, SEBLE G | reporter.nih.gov |
| IeDEA Asia-Pacific Research Collaboration | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,360,741 | July 15, 2006 | April 30, 2027 | SOHN, ANNETTE H | reporter.nih.gov |
| MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $14,117,524 | April 1, 2019 | September 30, 2026 | GUSTAFSON, DEBORAH R. | reporter.nih.gov |
| Center for Cancer Immunology and Immunotherapy (CCII) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $14,096,415 | February 1, 2020 | May 31, 2030 | YAN, JUN | reporter.nih.gov |
| Children's Oncology Group Pediatric Early Phase Clinical Trial Network | NIH | National Cancer Institute | 2021 to 2024 | $14,041,303 | May 3, 2024 | July 31, 2024 | WEIGEL, BRENDA J. | reporter.nih.gov |
| UNC MACS/WIHS Combined Cohort Study Clinical Research Site | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $13,957,792 | April 1, 2019 | September 30, 2026 | FLORIS-MOORE, MICHELLE | reporter.nih.gov |
| The University of Kansas Cancer Center | NIH | National Cancer Institute | 2021 to 2025 | $13,943,269 | July 11, 2012 | June 30, 2027 | JENSEN, ROY A. | reporter.nih.gov |
| NCI Community Oncology Research Program 2025 Extension Request | NIH | National Cancer Institute | 2021 to 2025 | $13,851,882 | August 1, 2014 | July 31, 2026 | IRVIN, WILLIAM J | reporter.nih.gov |
| Wisconsin NCI Community Oncology Research Program (WiNCORP) | NIH | National Cancer Institute | 2021 to 2025 | $13,851,021 | August 1, 2014 | July 31, 2026 | ONITILO, ADEDAYO A | reporter.nih.gov |
| Stephenson Cancer Center - Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $13,739,637 | May 1, 2018 | April 30, 2028 | MANNEL, ROBERT S. | reporter.nih.gov |
| Massey Cancer Center - Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $13,606,962 | December 1, 1995 | April 30, 2028 | WINN, ROBERT A. | reporter.nih.gov |
| University of Virginia Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $13,417,285 | September 16, 1997 | January 31, 2027 | LOUGHRAN, THOMAS P. | reporter.nih.gov |
| The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site | NIH | National Cancer Institute | 2021 to 2025 | $13,340,451 | August 1, 2025 | July 31, 2026 | DRESCHER, CHARLES | reporter.nih.gov |
| University of Kentucky Markey Cancer Center – Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $13,269,345 | July 8, 2013 | June 30, 2028 | EVERS, BERNARD MARK | reporter.nih.gov |
| Human Tumor Atlas Network: Data Coordinating Center | NIH | National Cancer Institute | 2023 to 2025 | $13,148,220 | September 30, 2018 | August 31, 2029 | GENTLEMAN, ROBERT C | reporter.nih.gov |
| Gulf South Clinical Trials Network (Gulf South NCORP) | NIH | National Cancer Institute | 2021 to 2025 | $13,144,481 | August 1, 2014 | July 31, 2026 | OCHOA, AUGUSTO C. | reporter.nih.gov |
| The Institute for Biomolecular Targeting | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $13,083,143 | May 15, 2016 | May 31, 2027 | MADDEN, DEAN R | reporter.nih.gov |
| The Sylvester Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $13,016,151 | July 10, 2019 | June 30, 2029 | NIMER, STEPHEN D. | reporter.nih.gov |
| MACS/WIHS -CCS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $12,990,830 | April 1, 2019 | September 30, 2026 | ALCAIDE, MARIA LUISA | reporter.nih.gov |
| HEALTH Center for Addictions Research and Cancer Prevention | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2024 | $12,882,144 | September 8, 2020 | April 30, 2026 | BEECH, BETTINA M. | reporter.nih.gov |
| Personalized Modeling of CAR-T Cell Immunotherapy Using iPSC-Derived Effectors and Patient- Derived Tumor Organoids | NIH | National Cancer Institute | 2023 to 2025 | $12,675,268 | March 1, 1997 | August 31, 2026 | LIBUTTI, STEVEN K. | reporter.nih.gov |
| NATIONAL CHILDHOOD CANCER REGISTRY (NCCR) | NIH | National Cancer Institute | 2021 to 2025 | $12,616,798 | July 1, 2022 | June 30, 2025 | KOHLER, BETSY | reporter.nih.gov |
| Georgetown University Lombardi Comprehensive Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $12,475,608 | July 1, 2025 | June 30, 2026 | WEINER, LOUIS M. | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $12,342,542 | February 1, 1997 | January 31, 2027 | MESA, RUBEN A. | reporter.nih.gov |
| Nebraska Center for Molecular Target Discovery and Development | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $12,120,081 | March 16, 2018 | June 30, 2028 | LEWIS, ROBERT E. | reporter.nih.gov |
| PDB MANAGEMENT BY THE RESEARCH COLLABORATORY FOR STRUCTURAL BIOINFORMATICS | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $12,006,722 | August 1, 2019 | September 18, 2024 | BURLEY, STEPHEN K | reporter.nih.gov |
| Center for Live Cell Genomics | NIH | National Human Genome Research Institute | 2021 to 2025 | $11,992,289 | September 15, 2021 | June 30, 2027 | HAUSSLER, DAVID H | reporter.nih.gov |
| (EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank | NIH | National Cancer Institute | 2021 to 2025 | $11,843,510 | September 1, 2020 | March 31, 2027 | NICOL, KATHLEEN | reporter.nih.gov |
| Center for Musculoskeletal Disease Research (CMDR) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,683,826 | February 16, 2018 | January 31, 2028 | O'BRIEN, CHARLES A | reporter.nih.gov |
| Medical University of South Carolina - Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $11,675,386 | April 1, 2009 | March 31, 2029 | DUBOIS, RAYMOND N. | reporter.nih.gov |
| Cancer Center Support (CORE) Grant | NIH | National Cancer Institute | 2021 to 2025 | $11,628,123 | August 1, 1997 | June 30, 2030 | PALUCKA, ANNA KAROLINA | reporter.nih.gov |
| Cancer Research Consortium of West Michigan (CRCWM) | NIH | National Cancer Institute | 2021 to 2025 | $11,366,311 | August 8, 2014 | July 31, 2026 | BUTLER, KATHLEEN YOST | reporter.nih.gov |
| Characterizing pediatric genomes through an optimized sequencing approach | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $11,335,114 | September 23, 2016 | August 31, 2025 | GRIMWOOD, JANE | reporter.nih.gov |
| University of Hawaii Cancer Center CCSG | NIH | National Cancer Institute | 2021 to 2025 | $11,301,895 | July 1, 1997 | July 31, 2029 | UENO, NAOTO T. | reporter.nih.gov |
| Center for Pre-Clinical Cancer Research | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,277,290 | March 1, 2021 | February 28, 2027 | FRANCIS, JOSEPH | reporter.nih.gov |
| A Follow-up Study for Causes of Cancer in Black Women | NIH | National Cancer Institute | 2021 to 2025 | $11,271,706 | September 21, 2012 | August 31, 2027 | PALMER, JULIE R | reporter.nih.gov |
| Carle Cancer Center NCI Community Oncology Research Program (NCORP) | NIH | National Cancer Institute | 2021 to 2025 | $11,214,272 | August 8, 2014 | July 31, 2026 | ROWLAND, KENDRITH MARTIN | reporter.nih.gov |
| Mays Cancer Center at UT Health SA | NIH | National Cancer Institute | 2021 to 2025 | $11,193,809 | August 1, 1997 | July 31, 2026 | ZHENG, LEI | reporter.nih.gov |
| PARTIAL SUPPORT OF THE STUDY ON FRONTIERS OF STATISTICS FOR SCIENCE AND ENGINEERING: 2035 AND BEYOND | NIH | Office of the Director, National Institutes of Health | 2021 to 2024 | $11,131,879 | August 15, 2024 | August 14, 2026 | DAY, ROBERT | reporter.nih.gov |
| Administrative Supplement for the NCI P30 CCSG to extend partnerships with comprehensive cancer control coalitions to study implementation of evidence-based cancer control interventions | NIH | National Cancer Institute | 2021 | $11,079,774 | January 1, 1997 | March 31, 2022 | LYNCH, THOMAS JAMES | reporter.nih.gov |
| SEER CORE INFRASTRUCTURE SUPPORT | NIH | National Cancer Institute | 2021 to 2025 | $10,969,554 | August 15, 2018 | April 30, 2026 | DOHERTY, JENNIFER | reporter.nih.gov |
| The MIT Superfund Research Program: A Systems Approach for the Protection of Human Health from Hazardous Chemicals | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $10,859,376 | September 1, 2017 | June 30, 2027 | ENGELWARD, BEVIN P. | reporter.nih.gov |
| Cancer Research of Wisconsin and Northern Michigan (CROWN) Consortium | NIH | National Cancer Institute | 2021 to 2025 | $10,811,170 | August 23, 2019 | July 31, 2026 | JASLOWSKI, ANTHONY J | reporter.nih.gov |
| CLINICAL TRIALS MONITORING SERVICE | NIH | National Cancer Institute | 2021 | $10,790,968 | May 1, 2017 | April 30, 2021 | ANDERSON, BARRY | reporter.nih.gov |
| Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics) | NIH | National Cancer Institute | 2022 to 2025 | $10,596,037 | September 22, 2022 | August 31, 2027 | HEATH, JAMES R. | reporter.nih.gov |
| STORAGE AND DISTRIBUTION OF CLINICAL AGENTS | NIH | National Cancer Institute | 2021 to 2022 | $10,577,768 | February 1, 2018 | January 31, 2023 | MEHRINFAR, MAHZAD | reporter.nih.gov |
| HIGH THROUGHPUT GENOTYPING AND DNA SEQUENCING FOR STUDYING THE GENETIC CONTRIBUTIONS TO HUMAN HEALTH AND DISEASE | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $10,443,705 | September 26, 2025 | September 25, 2028 | reporter.nih.gov | |
| SPORE in Brain Cancer | NIH | National Cancer Institute | 2021 to 2025 | $10,413,880 | September 1, 2008 | August 31, 2029 | LANG, FREDERICK F | reporter.nih.gov |
| MSK SPORE in Genomic Instability in Breast Cancer | NIH | National Cancer Institute | 2021 to 2025 | $10,402,609 | August 13, 2020 | July 31, 2026 | POWELL, SIMON N. | reporter.nih.gov |
| NIH Health Care Systems Research Collaboratory-Coordinating Center (U24) | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $10,249,994 | September 22, 2022 | May 31, 2028 | HERNANDEZ, ADRIAN | reporter.nih.gov |
| Kansas Center for Metabolism and Obesity REsearch (KC-MORE) | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $10,233,525 | April 1, 2022 | February 28, 2027 | WEINMAN, STEVEN A | reporter.nih.gov |
| The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study | NIH | National Cancer Institute | 2021 to 2025 | $10,080,862 | June 23, 2015 | March 31, 2026 | CERHAN, JAMES R | reporter.nih.gov |
| Colorado Head and Neck Cancer SPORE | NIH | National Cancer Institute | 2021 to 2025 | $10,073,085 | September 1, 2021 | August 31, 2026 | JIMENO, ANTONIO | reporter.nih.gov |
| Southern Liver Health Cohort | NIH | National Cancer Institute | 2023 to 2025 | $10,038,112 | September 21, 2021 | August 31, 2027 | HOYO, CATHRINE | reporter.nih.gov |
| The Pacific Northwest Prostate Cancer SPORE | NIH | National Cancer Institute | 2021 to 2025 | $9,924,776 | September 19, 2002 | August 31, 2028 | NELSON, PETER S | reporter.nih.gov |
| Georgia NCI Community Oncology Research Program (GA NCORP) | NIH | National Cancer Institute | 2021 to 2025 | $9,828,045 | August 9, 2014 | July 31, 2026 | CANTUARIA, GUILHERME | reporter.nih.gov |
| Yale SPORE in Skin Cancer | NIH | National Cancer Institute | 2021 to 2025 | $9,801,266 | June 1, 2006 | August 31, 2028 | BOSENBERG, MARCUS W | reporter.nih.gov |
| CP-CTNet Coordinating Center Year 6 - Aug 1, 2024 through July 31, 2025 | NIH | National Cancer Institute | 2021 to 2024 | $9,786,857 | September 20, 2019 | July 31, 2025 | EICKHOFF, JENS | reporter.nih.gov |
| Chronic Pancreatitis Clinical Research Consortium (CPCRC) Data Coordinating Center (CPCRC-DCC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $9,632,234 | September 28, 2015 | June 30, 2030 | LI, LIANG | reporter.nih.gov |
| Aurora NCORP Community Site | NIH | National Cancer Institute | 2021 to 2025 | $9,617,195 | August 15, 2014 | July 31, 2026 | SAPHNER, THOMAS J | reporter.nih.gov |
| Determining the mechanism of pks+ E.coli-associated carcinogenesis in early onset colorectal cancer. | NIH | National Cancer Institute | 2022 to 2025 | $9,558,240 | September 20, 2022 | August 31, 2027 | O'REILLY, EILEEN MARY | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2022 | $9,532,839 | March 1, 1997 | February 28, 2023 | LIBUTTI, STEVEN K. | reporter.nih.gov |
| CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT | NIH | National Cancer Institute | 2021 to 2022 | $9,504,731 | July 1, 2019 | February 28, 2023 | ALLEN, CHARLES | reporter.nih.gov |
| Clinical Trial Advancement and Development for Sarcomas | NIH | National Cancer Institute | 2022 to 2025 | $9,446,195 | September 11, 1997 | January 31, 2027 | VAN ETTEN, RICHARD A. | reporter.nih.gov |
| Predicting and Understanding the Use of Nicotine Products In a Rapidly Evolving Nicotine Marketplace: The International Nicotine Product, Policy, and Market (INPAM) Study | NIH | National Cancer Institute | 2021 to 2025 | $9,428,812 | April 19, 2016 | August 31, 2026 | CUMMINGS, KENNETH MICHAEL | reporter.nih.gov |
| Targeting the A2B Adenosine Receptor for Immunoprevention of Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2025 | $9,423,468 | September 15, 2023 | March 14, 2027 | WU, XIANGWEI | reporter.nih.gov |
| Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $9,412,704 | September 22, 2020 | June 30, 2026 | BURTNESS, BARBARA | reporter.nih.gov |
| Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study | NIH | National Cancer Institute | 2021 to 2025 | $9,251,154 | September 19, 2016 | August 31, 2026 | ULRICH, CORNELIA M | reporter.nih.gov |
| REGULATORY SERVICES AND TECHNICAL SUPPORT TO THE DIVISION OF CANCER PREVENTION (DCP) | NIH | National Cancer Institute | 2023 to 2025 | $9,188,070 | September 30, 2025 | September 29, 2026 | SIGMAN, CAROLINE | reporter.nih.gov |
| Translational Research in Breast Cancer | NIH | National Cancer Institute | 2021 to 2025 | $9,097,808 | September 19, 2014 | July 31, 2026 | ZHANG, XIANG | reporter.nih.gov |
| A Lead Academic Participating Site in Oklahoma for the Design and Conduct of NCTN Clinical Trials | NIH | National Cancer Institute | 2021 to 2025 | $8,980,562 | March 7, 2019 | February 28, 2026 | FURQAN, MUHAMMAD | reporter.nih.gov |
| Colon Cancer Family Registry Cohort | NIH | National Cancer Institute | 2021 to 2025 | $8,978,119 | May 1, 2013 | April 30, 2028 | JENKINS, MARK A | reporter.nih.gov |
| INTERNAL AND EXTERNAL COMMUNICATIONS AND DISSEMINATION SUPPORT FOR DCCPS | NIH | National Cancer Institute | 2022 to 2024 | $8,942,190 | September 15, 2022 | September 14, 2025 | KILGORE, ELIZABETH | reporter.nih.gov |
| SEER CORE INFRASTRUCTURE SUPPORT | NIH | National Cancer Institute | 2021 to 2025 | $8,932,215 | March 3, 2021 | April 30, 2026 | KOCH, LORI | reporter.nih.gov |
| SEER-LINKED VIRTUAL TISSUE REPOSITORY (VTR) PROGRAM | NIH | National Cancer Institute | 2021 to 2025 | $8,862,048 | September 15, 2023 | September 14, 2026 | WU, XIAO-CHENG | reporter.nih.gov |
| SEER CORE INFRASTRUCTURE SUPPORT | NIH | National Cancer Institute | 2021 to 2022 | $8,731,753 | May 1, 2018 | April 30, 2023 | SCHWARTZ, PHD, STEPHEN | reporter.nih.gov |
| Delaware Christiana Care NCORP | NIH | National Cancer Institute | 2021 to 2025 | $8,723,018 | August 1, 2014 | July 31, 2026 | MASTERS, GREGORY A | reporter.nih.gov |
| Statistical Methods for Integrative Genomics in Cancer | NIH | National Cancer Institute | 2021 to 2025 | $8,721,062 | July 1, 2016 | August 31, 2027 | GAUDERMAN, WILLIAM JAMES | reporter.nih.gov |
| Targeting Lung Cancer Vulnerabilities | NIH | National Cancer Institute | 2021 to 2024 | $8,708,604 | September 5, 1997 | August 31, 2025 | MINNA, JOHN D. | reporter.nih.gov |
| Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum Administrative Supplement | NIH | National Cancer Institute | 2021 to 2025 | $8,668,837 | September 1, 2020 | August 31, 2026 | TRENTHAM-DIETZ, AMY | reporter.nih.gov |
| Kids First Data Resource Center (KFDRC): Harnessing Data-Driven Opportunities in the Present on behalf of the Future of Common Fund Data Ecosystem (CFDE) | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $8,664,754 | September 25, 2025 | March 24, 2027 | RESNICK, ADAM CAIN | reporter.nih.gov |
| SEER CORE INFRASTRUCTURE SUPPORT | NIH | National Cancer Institute | 2021 to 2025 | $8,657,645 | May 1, 2018 | April 30, 2026 | HERNANDEZ, BRENDA | reporter.nih.gov |
| Infrastructure for Pathways, a Prospective Study of Breast Cancer Survivorship | NIH | National Cancer Institute | 2021 to 2025 | $8,656,392 | June 1, 2016 | May 31, 2027 | KUSHI, LAWRENCE H | reporter.nih.gov |
| Breast Cancer Family Registry | NIH | National Cancer Institute | 2021 to 2025 | $8,625,718 | September 12, 2012 | April 30, 2028 | TERRY, MARY BETH | reporter.nih.gov |
| The University of Kansas Cancer Center's- MCA Rural NCORP- extension | NIH | National Cancer Institute | 2021 to 2025 | $8,620,990 | August 13, 2019 | July 31, 2026 | DOOLITTLE, GARY C. | reporter.nih.gov |
| Polymerase theta, genome instability, and cancer | NIH | National Cancer Institute | 2021 to 2025 | $8,608,488 | July 1, 2020 | June 30, 2030 | RAMSDEN, DALE A | reporter.nih.gov |
| International Epidemiology Databases to EvaluateAIDS (IeDEA) Renewal 4 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,392,710 | July 1, 2006 | July 2, 2026 | JAQUET, ANTOINE | reporter.nih.gov |
| Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers | NIH | National Cancer Institute | 2021 to 2025 | $8,380,255 | September 15, 2020 | June 30, 2027 | KUSHI, LAWRENCE H | reporter.nih.gov |
| Southern Community Cohort Study | NIH | National Cancer Institute | 2021 to 2025 | $8,346,621 | July 21, 2016 | June 30, 2027 | ZHENG, WEI | reporter.nih.gov |
| SEER Core Infrastructure Support | NIH | National Cancer Institute | 2021 to 2025 | $8,318,181 | May 1, 2018 | April 30, 2026 | SCHYMURA, MARIA | reporter.nih.gov |
| Sex-based Differences in Glioma | NIH | National Cancer Institute | 2021 to 2025 | $8,258,328 | September 14, 2020 | December 31, 2026 | LATHIA, JUSTIN D. | reporter.nih.gov |
| Center of Biomedical Research Excellence in Matrix Biology Phase II | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $8,248,947 | August 1, 2014 | May 31, 2025 | OXFORD, JULIA THOM | reporter.nih.gov |
| A Multicenter Randomized Controlled Trial of Surveillance versus. Endoscopic Therapy for Barretts Esophagus with Low-grade Dysplasia: The SURVENT Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $8,184,774 | May 15, 2022 | April 30, 2027 | WANI, SACHIN | reporter.nih.gov |
| CCDI SUPPORT FOR NIH/NCI/DCCPS SURVEILLANCE RESEARCH PROGRAM | NIH | National Cancer Institute | 2021 to 2025 | $8,176,428 | August 16, 2021 | August 15, 2026 | reporter.nih.gov | |
| The NCI Community Oncology Research Program: The New Mexico NCORP | NIH | National Cancer Institute | 2021 to 2025 | $8,085,672 | August 9, 2014 | July 31, 2026 | MULLER, CAROLYN Y. | reporter.nih.gov |
| Medical Scientist Training Program | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $7,940,810 | July 1, 2022 | June 30, 2027 | CHUA, KATRIN F. | reporter.nih.gov |
| Multi-Consortia Coordinating Center (MC2 Center) for Cancer Biology: Building Interdisciplinary Scientific Communities, Coordinating Impactful Resource Sharing, and Advancing Cancer Research | NIH | National Cancer Institute | 2022 to 2025 | $7,938,662 | September 14, 2022 | August 31, 2027 | VARMA, SUSHEEL | reporter.nih.gov |
| SUPPORT SERVICES FOR THE CTEP PHARMACEUTICAL MANAGEMENT BRANCH (PMB) | NIH | National Cancer Institute | 2022 to 2025 | $7,922,356 | September 1, 2022 | August 31, 2026 | GRAY, ARIE | reporter.nih.gov |
| Biospecimen Core Resource (BCR) services | NIH | National Cancer Institute | 2022 | $7,912,119 | June 28, 2022 | June 27, 2027 | JEWELL, SCOTT | reporter.nih.gov |
| Stanford Tissue Mapping Center | NIH | National Human Genome Research Institute | 2022 to 2025 | $7,785,758 | September 23, 2022 | June 30, 2026 | SNYDER, MICHAEL P. | reporter.nih.gov |
| PDB Management by the Research Collaboratory for Structural Bioinformatics | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $7,760,000 | September 30, 2024 | July 31, 2029 | BURLEY, STEPHEN K | reporter.nih.gov |
| Cancer Epidemiology Cohort in Male Health Professionals | NIH | National Cancer Institute | 2021 to 2025 | $7,706,351 | August 21, 2012 | July 31, 2027 | MUCCI, LORELEI | reporter.nih.gov |
| Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome | NIH | National Cancer Institute | 2022 to 2025 | $7,696,898 | September 20, 2022 | August 31, 2027 | GRADY, WILLIAM MALLORY | reporter.nih.gov |
| Base Title: PREVENT Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint BiomarkersTask Order Title: Colorectal Cancer (CRC) Prevention by TPST-1495 in PIRC rat mod | NIH | National Cancer Institute | 2021 to 2023 | $7,628,615 | September 11, 2023 | September 10, 2026 | RAO, CHINTHALAPALLY | reporter.nih.gov |
| Early Phase Clinical Cancer Prevention Consortium | NIH | National Cancer Institute | 2021 to 2025 | $7,613,555 | July 7, 2020 | July 31, 2031 | SCHUETZE, SCOTT MICHAEL | reporter.nih.gov |
| Extending the Diversity, Reach, and Generalizability of the WISDOM Study | NIH | National Cancer Institute | 2021 to 2024 | $7,580,298 | March 1, 2020 | February 28, 2026 | ESSERMAN, LAURA J | reporter.nih.gov |
| University of Arizona Cancer Prevention Clinical Trials Network | NIH | National Cancer Institute | 2021 to 2025 | $7,572,043 | August 16, 2019 | July 31, 2031 | THOMPSON, PATRICIA ANN | reporter.nih.gov |
| DRUG DEVELOPMENT SUPPORT FOR THE CANCER THERAPY EVALUATION PROGRAM (CTEP) | NIH | National Cancer Institute | 2021 | $7,562,000 | July 1, 2015 | June 30, 2022 | SAUNDERS, JOAN | reporter.nih.gov |
| CONNECT TASK ORDER 8 | NIH | National Cancer Institute | 2024 | $7,553,399 | September 27, 2024 | September 19, 2025 | RYBICKI, BENJAMIN | reporter.nih.gov |
| Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP) | NIH | National Cancer Institute | 2021 to 2025 | $7,542,201 | August 14, 2014 | July 31, 2026 | PANIKKAR, RAJIV | reporter.nih.gov |
| SPORE in Breast Cancer | NIH | National Cancer Institute | 2021 to 2024 | $7,513,457 | August 1, 2024 | July 31, 2025 | PIETENPOL, JENNIFER A | reporter.nih.gov |
| Northern Pacific Global Health Leadership, Education, and Development for Early-career Researchers (NPGH LEADERs) | NIH | Fogarty International Center | 2021 to 2025 | $7,366,373 | July 1, 2025 | June 30, 2026 | ZUNT, JOSEPH RAYMOND | reporter.nih.gov |
| Multi-Omics DACC: The Data Analysis and Coordination Center for the collaborative multi-omics for health and disease initiative | NIH | National Human Genome Research Institute | 2023 to 2025 | $7,356,094 | September 12, 2023 | September 22, 2028 | WENG, ZHIPING | reporter.nih.gov |
| NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required) | NIH | National Cancer Institute | 2021 to 2025 | $7,267,101 | August 1, 2014 | July 31, 2026 | ELLERTON, JOHN A | reporter.nih.gov |
| UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAPS) UG1 | NIH | National Cancer Institute | 2021 to 2025 | $7,237,503 | March 5, 2019 | February 28, 2026 | TSAO, ANNE S | reporter.nih.gov |
| REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY, EVALUATION AND DEVELOPMENT | NIH | National Cancer Institute | 2023 to 2025 | $7,231,030 | March 1, 2024 | February 28, 2025 | SCHROCK, RICHARD | reporter.nih.gov |
| NCI Cancer Screening Research Network: Coordinating and Communication Center | NIH | National Cancer Institute | 2024 to 2025 | $7,230,152 | February 9, 2024 | December 31, 2027 | ANDERSON, GARNET L. | reporter.nih.gov |
| LOW-DOSE COMPUTED TOMOGRAPHY IMAGES AND CORRESPONDING DATA | NIH | National Cancer Institute | 2022 to 2024 | $7,205,078 | September 16, 2022 | September 15, 2025 | FERNANDEZ, ANNA | reporter.nih.gov |
| Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting | NIH | National Cancer Institute | 2023 to 2025 | $7,201,689 | June 1, 2021 | May 31, 2027 | AMBROSONE, CHRISTINE B. | reporter.nih.gov |
| Coordinating center for the NCI small cell lung cancer research consortium | NIH | National Cancer Institute | 2021 to 2025 | $7,127,674 | June 24, 2022 | May 31, 2027 | RUDIN, CHARLES M. | reporter.nih.gov |
| NCORP of the Carolinas (Greenville Health System NCORP) | NIH | National Cancer Institute | 2021 to 2025 | $7,114,630 | June 2, 2025 | July 31, 2026 | CHUNG, KI YOUNG | reporter.nih.gov |
| Southern Environmental Health Study | NIH | National Cancer Institute | 2023 to 2025 | $7,106,860 | September 1, 2023 | August 31, 2028 | ZHENG, WEI | reporter.nih.gov |
| Northwestern Cancer Prevention Consortium | NIH | National Cancer Institute | 2021 to 2025 | $7,062,222 | September 3, 2019 | July 31, 2031 | KHAN, SEEMA AHSAN | reporter.nih.gov |
| iCAN PREVENT: MD Anderson International Cancer Prevention Clinical Trials Consortium | NIH | National Cancer Institute | 2021 to 2025 | $7,046,172 | August 15, 2019 | July 31, 2031 | VILAR SANCHEZ, EDUARDO | reporter.nih.gov |
| Dana-Farber/Harvard Cancer Center Experimental Therapeutics Clinical Trials Network Site (DF/HCC ETCTN Site) | NIH | National Cancer Institute | 2021 to 2025 | $7,018,946 | March 13, 2014 | February 28, 2027 | SHAPIRO, GEOFFREY I. | reporter.nih.gov |
| UCSF Older Americans Independence Center | NIH | National Institute on Aging | 2021 to 2025 | $6,946,581 | July 15, 2013 | June 30, 2028 | COVINSKY, KENNETH E. | reporter.nih.gov |
| PharmGKB | NIH | National Human Genome Research Institute | 2021 to 2025 | $6,940,000 | April 3, 2020 | December 31, 2026 | KLEIN, TERI ELLEN | reporter.nih.gov |
| The Global Alliance for Genomics and Health: Setting the Standards for Genomics and Health-Related Data Sharing | NIH | National Human Genome Research Institute | 2021 to 2025 | $6,892,586 | February 5, 2021 | January 31, 2027 | REHM, HEIDI L | reporter.nih.gov |
| WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC): TASK AREA A AND A2 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,882,445 | September 29, 2025 | September 28, 2026 | WACTAWSKI-WENDE, JEAN | reporter.nih.gov |
| Case Comprehensive Cancer Center NCTN Lead Academic Participating Site | NIH | National Cancer Institute | 2021 to 2025 | $6,875,260 | March 15, 2019 | February 28, 2026 | GERDS, AARON THOMAS | reporter.nih.gov |
| The 10,000 Families Cohort: a new study to understand the environmental causes of cancer | NIH | National Cancer Institute | 2023 to 2025 | $6,827,634 | September 24, 2021 | August 31, 2028 | POYNTER, JENNY N. | reporter.nih.gov |
| Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy. | NIH | National Cancer Institute | 2021 to 2025 | $6,769,276 | March 1, 2021 | August 31, 2027 | KAHALLEY, LISA SCHUM | reporter.nih.gov |
| The Hawaii NCORP | NIH | National Cancer Institute | 2021 to 2025 | $6,768,379 | August 1, 2014 | July 31, 2026 | ACOBA, JARED | reporter.nih.gov |
| PROMINENT - UCSF | NIH | National Cancer Institute | 2022 to 2025 | $6,721,823 | June 22, 2022 | May 31, 2026 | BALMAIN, ALLAN | reporter.nih.gov |
| Georgia CaRes | NIH | National Cancer Institute | 2021 to 2025 | $6,645,840 | August 1, 2014 | July 31, 2026 | GHAMANDE, SHARAD A. | reporter.nih.gov |
| Iowa-Wide Oncology Research Coalition (I-WORC) | NIH | National Cancer Institute | 2021 to 2025 | $6,645,413 | August 1, 2014 | July 31, 2026 | HARICHAND, SEEMA | reporter.nih.gov |
| California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations | NIH | National Cancer Institute | 2021 to 2025 | $6,605,241 | September 12, 2019 | July 31, 2026 | PALEFSKY, JOEL MICHAEL | reporter.nih.gov |
| University of Florida Health Cancer Center Support Grant | NIH | National Cancer Institute | 2023 to 2025 | $6,600,879 | June 1, 2023 | May 31, 2027 | GEORGE, THOMAS J. | reporter.nih.gov |
| Coordinating and Data Management Center for Acquired Resistance to Therapy Network | NIH | National Cancer Institute | 2022 to 2025 | $6,584,333 | May 1, 2025 | April 30, 2026 | HUTSON, ALAN DAVID | reporter.nih.gov |
| Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center | NIH | National Cancer Institute | 2021 to 2025 | $6,578,630 | March 6, 2019 | February 28, 2026 | AGHAJANIAN, CAROL | reporter.nih.gov |
| Washington University/Siteman Cancer Center Lead Academic Site | NIH | National Cancer Institute | 2021 to 2025 | $6,572,668 | March 5, 2019 | February 28, 2026 | BARTLETT, NANCY L | reporter.nih.gov |
| Comparative Modeling to Inform Cervical Cancer Control Policies | NIH | National Cancer Institute | 2021 to 2024 | $6,568,988 | September 8, 2020 | August 31, 2025 | KIM, JANE JOOYUN | reporter.nih.gov |
| The MW Cancer Prevention Clinical Trials Network | NIH | National Cancer Institute | 2021 to 2024 | $6,549,528 | September 3, 2020 | July 31, 2026 | BARROILHET, LISA M | reporter.nih.gov |
| Transcriptomic classification of non-muscle invasive bladder cancer and its clinical and prognostic implication | NIH | National Cancer Institute | 2022 to 2025 | $6,547,653 | September 1, 2025 | August 31, 2027 | TANG, LI | reporter.nih.gov |
| Establishing and Interpreting Abnormal DNA Methylation in Cancer | NIH | National Cancer Institute | 2021 to 2025 | $6,541,625 | January 1, 2017 | June 30, 2030 | JONES, PETER A | reporter.nih.gov |
| WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC): TASK AREA A AND A2 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,534,889 | September 29, 2025 | September 28, 2026 | STEFANICK, MARCIA | reporter.nih.gov |
| Multi-level Optimization of the Cervical Cancer Screening Process in Diverse Settings & Populations (METRICS) | NIH | National Cancer Institute | 2021 to 2023 | $6,487,883 | April 10, 2018 | March 31, 2025 | HUGHES, AMY E | reporter.nih.gov |
| Whole Person Reference Physiome Research and Coordination Center | NIH | National Center for Complementary & Integrative Health | 2025 | $6,476,031 | August 8, 2025 | July 31, 2028 | SNYDER, MICHAEL P. | reporter.nih.gov |
| Decoding mechanisms underlying metabolic dysregulation in obesity and digestive cancer risk | NIH | National Cancer Institute | 2022 to 2025 | $6,443,697 | September 20, 2022 | August 31, 2027 | TOBIAS, DEIRDRE KAY | reporter.nih.gov |
| The Cleveland Digestive Diseases Research Core Center (DDRCC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,425,666 | February 15, 2015 | August 31, 2030 | COMINELLI, FABIO | reporter.nih.gov |
| CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan | NIH | National Cancer Institute | 2023 to 2025 | $6,381,605 | September 22, 2021 | August 31, 2027 | FRIEDMAN, DEBRA L. | reporter.nih.gov |
| Biomarker Rich Clinical Trial of an Innovative Antibody Antagonist of TNFR2 in Non-Hodgkin Lymphoma Featuring Cutaneous T Cell Lymphoma (CTCL). | NIH | National Cancer Institute | 2021 to 2025 | $6,371,380 | September 1, 2021 | June 30, 2027 | BROOKS, DAVID G | reporter.nih.gov |
| Baptist Memorial Health Care/Mid South NCORP Consortium | NIH | National Cancer Institute | 2021 to 2025 | $6,358,705 | August 1, 2014 | July 31, 2026 | OSAROGIAGBON, RAYMOND U. | reporter.nih.gov |
| Synergistic role of signaling and epigenetics in leukemic transformation | NIH | National Cancer Institute | 2021 to 2025 | $6,322,598 | January 17, 2017 | July 31, 2030 | LEVINE, ROSS L | reporter.nih.gov |
| PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial | NIH | National Institute on Aging | 2022 to 2025 | $6,295,083 | February 15, 2022 | January 31, 2027 | BRINTON, ROBERTA EILEEN | reporter.nih.gov |
| Northwell Health NCORP | NIH | National Cancer Institute | 2021 to 2025 | $6,289,305 | August 7, 2014 | July 31, 2026 | VINCIGUERRA, VINCENT P | reporter.nih.gov |
| Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies | NIH | National Cancer Institute | 2022 to 2025 | $6,280,793 | September 14, 2022 | July 31, 2027 | CHAN, TIMOTHY AN-THY | reporter.nih.gov |
| Detroit Research on Cancer Survivors (Detroit ROCS) | NIH | National Cancer Institute | 2021 to 2025 | $6,266,318 | February 27, 2017 | February 28, 2027 | SCHWARTZ, ANN G. | reporter.nih.gov |
| Translating genomic discoveries to improved outcomes for high risk acute leukemia | NIH | National Cancer Institute | 2021 to 2025 | $6,239,168 | January 19, 2017 | August 31, 2030 | MULLIGHAN, CHARLES G | reporter.nih.gov |
| BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERSTASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND LYNCH SYNDROME-ASSOCIA | NIH | National Cancer Institute | 2022 to 2024 | $6,227,249 | June 15, 2022 | May 15, 2025 | CLAPPER, MARGIE L. | reporter.nih.gov |
| STRATEGIC COMMUNICATIONS AND ANALYTIC SUPPORT FOR DCCPS | NIH | National Cancer Institute | 2022 | $6,140,000 | September 30, 2022 | September 29, 2023 | GEAGHAN, TAYLOR | reporter.nih.gov |
| Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy | NIH | National Cancer Institute | 2021 to 2025 | $6,132,390 | May 6, 2021 | April 30, 2027 | KOLB, NOAH ALLAN | reporter.nih.gov |
| Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE) | NIH | National Cancer Institute | 2021 to 2023 | $6,108,355 | April 15, 2018 | March 31, 2025 | CORLEY, DOUGLAS ALLEN | reporter.nih.gov |
| The Boston Lung Cancer Survival Cohort | NIH | National Cancer Institute | 2021 to 2025 | $6,033,521 | June 1, 2017 | May 31, 2028 | CHRISTIANI, DAVID C | reporter.nih.gov |
| Center for Research to Optimize Precision Lung Cancer Screening in Diverse Populations | NIH | National Cancer Institute | 2021 to 2023 | $6,033,066 | April 15, 2018 | July 31, 2025 | RITZWOLLER, DEBRA P | reporter.nih.gov |
| EFIRM Liquid Biopsy Research Laboratory: Early Lung Cancer Assessment | NIH | National Cancer Institute | 2021 to 2025 | $6,012,718 | September 13, 2018 | August 31, 2028 | WONG, DAVID T | reporter.nih.gov |
| The Johns Hopkins Translational Science Team and Consortium for ETCTN Studies | NIH | National Cancer Institute | 2021 to 2025 | $6,006,072 | March 13, 2014 | February 28, 2027 | CARDUCCI, MICHAEL A | reporter.nih.gov |
| Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico | NIH | National Cancer Institute | 2021 to 2025 | $5,948,066 | September 20, 2019 | July 31, 2026 | ELLSWORTH, GRANT B. | reporter.nih.gov |
| Metabolic gatekeepers in B-cell malignancies | NIH | National Cancer Institute | 2021 to 2025 | $5,936,594 | April 1, 2016 | August 31, 2028 | MÜSCHEN, MARKUS | reporter.nih.gov |
| The cBioPortal for Cancer Genomics | NIH | National Cancer Institute | 2022 to 2025 | $5,919,979 | September 5, 2022 | August 31, 2027 | SCHULTZ, NIKOLAUS | reporter.nih.gov |
| Innovative Infrastructure to Enhance and Sustain the California Teachers Study Cohort | NIH | National Cancer Institute | 2021 to 2024 | $5,912,553 | September 1, 2015 | August 31, 2025 | LACEY, JAMES V | reporter.nih.gov |
| Ozark Health Ventures LLC dba Cancer Research for the Ozarks (CRO) | NIH | National Cancer Institute | 2021 to 2025 | $5,870,896 | August 1, 2014 | July 31, 2026 | CARLSON, JAY W | reporter.nih.gov |
| High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials | NIH | National Cancer Institute | 2023 to 2025 | $5,867,691 | September 30, 2017 | June 30, 2028 | GNJATIC, SACHA | reporter.nih.gov |
| VCU Massey Comprehensive Cancer Center NCI Community Oncology Research Program | NIH | National Cancer Institute | 2021 to 2025 | $5,851,780 | August 1, 2014 | July 31, 2026 | MATIN, KHALID | reporter.nih.gov |
| Essentia Health Community Cancer Research Program - NCORP | NIH | National Cancer Institute | 2021 to 2025 | $5,823,202 | August 9, 2014 | July 31, 2026 | FRIDAY, BRET E.B. | reporter.nih.gov |
| Annotating Cancer Biology through Non-Invasive Molecular Imaging | NIH | National Cancer Institute | 2021 to 2025 | $5,790,675 | September 4, 2019 | August 31, 2026 | LEWIS, JASON S. | reporter.nih.gov |
| Cancer Immune Monitoring and Analysis Center | NIH | National Cancer Institute | 2023 to 2025 | $5,746,876 | September 30, 2017 | June 30, 2028 | WU, CATHERINE JU-YING | reporter.nih.gov |
| Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,725,440 | August 1, 2017 | July 31, 2031 | SHAW, REUBEN | reporter.nih.gov |
| Regulatory Support for Cancer Prevention Agent Development | NIH | National Cancer Institute | 2021 to 2022 | $5,713,085 | September 30, 2022 | September 29, 2023 | SIGMAN, CAROLINE | reporter.nih.gov |
| Histidine phosphorylation as a new target for cancer therapy | NIH | National Cancer Institute | 2021 to 2025 | $5,690,698 | September 18, 2019 | August 31, 2026 | HUNTER, TONY R. | reporter.nih.gov |
| Pediatric Solid Tumor Microenvironment Atlas | NIH | National Cancer Institute | 2024 to 2025 | $5,678,350 | September 1, 2024 | August 31, 2029 | ASGHARZADEH, SHAHAB | reporter.nih.gov |
| MD Anderson Cancer Immune Monitoring and Analysis Center MDA-CIMAC | NIH | National Cancer Institute | 2023 to 2025 | $5,677,452 | September 30, 2017 | June 30, 2028 | HAYMAKER, CARA L | reporter.nih.gov |
| Identifying Multilevel Drivers of Differences in Ovarian Cancer Treatment and Survival: An Integrative Approach | NIH | National Cancer Institute | 2021 to 2025 | $5,668,317 | July 1, 2020 | June 30, 2027 | DOHERTY, JENNIFER ANNE | reporter.nih.gov |
| Overcoming resistance to anti-PD1 immunotherapy | NIH | National Cancer Institute | 2021 to 2025 | $5,629,363 | December 7, 2016 | August 31, 2030 | GAJEWSKI, THOMAS F | reporter.nih.gov |
| OSU as a Network Lead Academic Participating Site for the NCI NCTN | NIH | National Cancer Institute | 2021 to 2025 | $5,610,699 | March 28, 2019 | February 28, 2026 | VERSCHRAEGEN, CLAIRE F. | reporter.nih.gov |
| PDX Trial Center for Breast Cancer Therapy | NIH | National Cancer Institute | 2021 to 2025 | $5,609,196 | September 25, 2017 | June 30, 2028 | WELM, ALANA L. | reporter.nih.gov |
| SCIENTIFIC SUPPORT SERVICES FOR THE NATIONAL CANCER INSTITUTE, DIVISION OF CANCER CONTROL AND POPULATION SCIENCES (DCCPS), CALL ORDER 3 UNDER BPA #HHSN261201800002B | NIH | National Cancer Institute | 2023 to 2024 | $5,606,948 | July 27, 2023 | July 26, 2025 | WOODY, TORRISE | reporter.nih.gov |
| Mutographs differentiating the inheritance and temporal onset of multiple myeloma | NIH | National Cancer Institute | 2021 to 2025 | $5,575,548 | August 11, 2021 | July 31, 2026 | MORGAN, GARETH JOHN | reporter.nih.gov |
| Development and Optimization of MNK Inhibitors for the Treatment of Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $5,575,218 | September 1, 2021 | August 31, 2025 | SAHN, JAMES JEFFREY | reporter.nih.gov |
| The role of stem cells and the microenvironment in gastrointestinal cancers | NIH | National Cancer Institute | 2021 to 2025 | $5,569,272 | January 7, 2016 | August 31, 2030 | WANG, TIMOTHY CRAGIN | reporter.nih.gov |
| Myeloma multidimensional precancer atlas | NIH | National Cancer Institute | 2024 to 2025 | $5,566,942 | September 18, 2024 | August 31, 2029 | GHOBRIAL, IRENE M. | reporter.nih.gov |
| Cervical, Anal & Oral HPV Persistence/Adolescent Girls | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,549,203 | May 15, 2007 | January 31, 2028 | DIAZ, ANGELA | reporter.nih.gov |
| Stanford Cancer Immune Monitoring and Analysis Center (CIMAC) | NIH | National Cancer Institute | 2023 to 2025 | $5,504,598 | September 30, 2017 | June 30, 2028 | MAECKER, HOLDEN T. | reporter.nih.gov |
| PROVIDE A VARIETY OF CRITICAL CANCER PREVENTION INFORMATION MANAGEMENT FUNCTIONS | NIH | National Cancer Institute | 2023 to 2025 | $5,502,992 | September 30, 2025 | September 29, 2026 | SIGMAN, CAROLINE | reporter.nih.gov |
| Finding Sleeping Beauty: T Cell Biosensors for Dormant Cancer Detection | NIH | National Cancer Institute | 2022 to 2025 | $5,481,630 | September 20, 2022 | August 31, 2027 | KWONG, GABRIEL A | reporter.nih.gov |
| Proteogenomic Characterization of Tumor Tissues and Preclinical Models with High Precision | NIH | National Cancer Institute | 2022 to 2025 | $5,481,323 | June 1, 2022 | May 31, 2027 | ZHANG, HUI | reporter.nih.gov |
| ASPiRE: Advancing Science & Practice in the Retail Environment | NIH | National Cancer Institute | 2021 to 2023 | $5,479,825 | September 1, 2018 | August 31, 2025 | RIBISL, KURT M. | reporter.nih.gov |
| Effects of Intermittent Energy Restriction on Intra-Abdominal Fat and the Gut Microbiome: A Randomized Trial | NIH | National Cancer Institute | 2021 to 2025 | $5,478,236 | September 22, 2021 | August 31, 2026 | LE MARCHAND, LOIC | reporter.nih.gov |
| Molecular mechanisms of antibody-mediated immunotherapies | NIH | National Cancer Institute | 2021 to 2025 | $5,461,259 | April 1, 2016 | August 31, 2029 | RAVETCH, JEFFREY VICTOR | reporter.nih.gov |
| Chemical Proteomic Platforms for Radically Expanding Cancer Druggability | NIH | National Cancer Institute | 2021 to 2025 | $5,455,828 | September 1, 2018 | August 31, 2032 | CRAVATT, BENJAMIN F | reporter.nih.gov |
| REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY EVALUATION AND DEVELOPMENT | NIH | National Cancer Institute | 2021 to 2024 | $5,446,831 | March 1, 2016 | February 27, 2021 | LEE, MARK | reporter.nih.gov |
| Washington University PDX Development and Trial Center | NIH | National Cancer Institute | 2021 to 2025 | $5,436,401 | September 30, 2017 | July 31, 2028 | DING, LI | reporter.nih.gov |
| NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care | NIH | National Cancer Institute | 2021 to 2025 | $5,422,908 | March 5, 2019 | February 28, 2026 | BURSTEIN, HAROLD JOHN | reporter.nih.gov |
| Center for Advanced Multi-Omic Characterization of Cancer | NIH | National Cancer Institute | 2022 to 2025 | $5,390,170 | June 1, 2022 | May 31, 2027 | LIU, TAO | reporter.nih.gov |
| CYTOSCAPE: AN ECOSYSTEM FOR NETWORK GENOMICS | NIH | National Human Genome Research Institute | 2022 to 2025 | $5,378,912 | September 1, 2022 | June 30, 2027 | IDEKER, TREY | reporter.nih.gov |
| 2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Center | NIH | National Cancer Institute | 2021 to 2025 | $5,355,395 | September 17, 2018 | August 31, 2028 | WILKIE, DIANA J | reporter.nih.gov |
| eDyNAmiC - STANFORD | NIH | National Cancer Institute | 2022 to 2025 | $5,333,113 | June 1, 2025 | May 31, 2026 | MISCHEL, PAUL S | reporter.nih.gov |
| STAKEHOLDER ENGAGEMENT AND OUTREACH SUPPORT FOR HEALTH BEHAVIOR CHANGE AND CANCER CONTROL RESOURCES | NIH | National Cancer Institute | 2023 to 2025 | $5,325,929 | September 1, 2023 | August 31, 2026 | KENDRICK, BRANDON | reporter.nih.gov |
| Cancer Grand Challenges: Operations Management Application | NIH | National Cancer Institute | 2021 to 2025 | $5,320,487 | May 10, 2021 | April 30, 2026 | SCOTT, DAVID | reporter.nih.gov |
| Texas EXperimental Cancer Therapeutics Network - TEX CTN | NIH | National Cancer Institute | 2023 to 2025 | $5,310,583 | March 14, 2014 | February 28, 2027 | MERIC-BERNSTAM, FUNDA | reporter.nih.gov |
| Targeting intratumor heterogeneity in breast cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,301,919 | August 1, 2015 | July 31, 2029 | POLYAK, KORNELIA | reporter.nih.gov |
| Adapting MultiPLe behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health | NIH | National Cancer Institute | 2021 to 2023 | $5,295,451 | September 1, 2018 | August 31, 2025 | DEMARK-WAHNEFRIED, WENDY | reporter.nih.gov |
| The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials Network | NIH | National Cancer Institute | 2021 to 2025 | $5,286,341 | March 28, 2014 | February 28, 2027 | CARSON, WILLIAM E. | reporter.nih.gov |
| SEER CORE INFRASTRUCTURE SUPPORT | NIH | National Cancer Institute | 2021 to 2025 | $5,284,354 | May 1, 2021 | April 30, 2026 | WILLIAMS, MELANIE | reporter.nih.gov |
| Understanding the role of tumor microenvironment in low grade glioma progression to malignancy | NIH | National Cancer Institute | 2024 to 2025 | $5,275,940 | September 1, 2024 | August 31, 2029 | CAI, LONG | reporter.nih.gov |
| Cell plasticity in the origin of gastric carcinogenesis | NIH | National Cancer Institute | 2022 to 2025 | $5,262,457 | September 1, 2025 | August 31, 2027 | CHOI, EUNYOUNG | reporter.nih.gov |
| CASCADE Coordinating Center | NIH | National Cancer Institute | 2022 to 2025 | $5,257,059 | September 7, 2022 | May 31, 2027 | SIMINSKI, SUZANNE M. | reporter.nih.gov |
| Optimizing the use of ketamine to reduce chronic postsurgical pain | NIH | National Cancer Institute | 2021 to 2024 | $5,247,593 | September 17, 2021 | August 31, 2025 | WANG, JING | reporter.nih.gov |
| Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery | NIH | National Cancer Institute | 2021 to 2025 | $5,246,301 | August 1, 2015 | July 31, 2028 | MEYERSON, MATTHEW L. | reporter.nih.gov |
| Structure, mechanism, and pharmacology of BRAF and its partners in the RAS/RAF/MAP kinase pathway | NIH | National Cancer Institute | 2021 to 2025 | $5,243,880 | September 1, 2019 | August 31, 2026 | ECK, MICHAEL J | reporter.nih.gov |
| Innate immune sensors, inflammasomes, and inflammasome-mediated processes in cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,241,422 | July 21, 2020 | June 30, 2027 | KANNEGANTI, THIRUMALA-DEVI | reporter.nih.gov |
| MECHANISMS OF REGULATED CELL DEATH | NIH | National Cancer Institute | 2021 to 2025 | $5,239,428 | September 1, 2018 | August 31, 2029 | GREEN, DOUGLAS R. | reporter.nih.gov |
| Comparative Modeling of Effective Policies for Colorectal Cancer Control | NIH | National Cancer Institute | 2021 to 2025 | $5,238,594 | July 1, 2025 | August 31, 2026 | ZAUBER, ANN GRAHAM | reporter.nih.gov |
| North American Star Consortium | NIH | National Cancer Institute | 2021 to 2025 | $5,236,760 | April 7, 2014 | February 28, 2027 | BEDARD, PHILIPPE | reporter.nih.gov |
| Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies. | NIH | National Cancer Institute | 2021 to 2025 | $5,214,422 | August 14, 2020 | July 31, 2027 | SCHEINBERG, DAVID A | reporter.nih.gov |
| Novel therapeutic development for small cell lung cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,214,420 | August 10, 2021 | July 31, 2028 | RUDIN, CHARLES M. | reporter.nih.gov |
| Chromosome Instability Drives Metal-Induced Lung Cancer | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $5,203,730 | August 1, 2021 | June 30, 2029 | WISE, JOHN PIERCE | reporter.nih.gov |
| Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,186,053 | August 24, 2015 | July 31, 2028 | WALENSKY, LOREN DAVID | reporter.nih.gov |
| Pre-cancer atlas of skin cancer | NIH | National Cancer Institute | 2024 to 2025 | $5,182,743 | September 1, 2024 | August 31, 2029 | SHAIN, ALAN HUNTER | reporter.nih.gov |
| The TGFÃÂÃÂÃÂò Signaling Pathway in Development and Cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,182,391 | September 1, 2020 | August 31, 2027 | MASSAGUE, JOAN | reporter.nih.gov |
| #4Corners4Health: A Social Media Cancer Prevention Program for Rural Emerging Adults | NIH | National Cancer Institute | 2022 to 2025 | $5,181,703 | September 8, 2022 | August 31, 2027 | BULLER, DAVID B | reporter.nih.gov |
| Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations | NIH | National Cancer Institute | 2021 to 2025 | $5,173,906 | August 8, 2019 | July 31, 2026 | DECAPRIO, JAMES A. | reporter.nih.gov |
| Genomic and Genomic Variation in Prostate Cancer | NIH | National Cancer Institute | 2022 to 2025 | $5,164,514 | January 7, 2022 | April 30, 2027 | REBBECK, TIMOTHY RICHARD | reporter.nih.gov |
| Human Prostate Tumor Atlas Center | NIH | National Cancer Institute | 2024 to 2025 | $5,162,603 | September 1, 2024 | August 31, 2029 | DING, LI | reporter.nih.gov |
| Reading mitochondrial apoptotic signaling to identify active cancer therapeutics | NIH | National Cancer Institute | 2021 to 2025 | $5,159,959 | August 1, 2019 | September 29, 2025 | LETAI, ANTHONY G | reporter.nih.gov |
| A Multimodal 3D Atlas of Colorectal Cancer Across Ages of Onset | NIH | National Cancer Institute | 2024 to 2025 | $5,159,940 | September 1, 2024 | August 31, 2029 | LAU, KEN S | reporter.nih.gov |
| Center for Gastric Pre-Cancer Atlas of Multidimensional Evolution in 3D (GAME3D) | NIH | National Cancer Institute | 2024 to 2025 | $5,158,661 | September 1, 2024 | August 31, 2029 | WANG, LINGHUA | reporter.nih.gov |
| Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers | NIH | National Cancer Institute | 2021 to 2025 | $5,154,412 | September 1, 2019 | August 31, 2026 | ROBERTS, THOMAS M | reporter.nih.gov |
| MaineHealth Cancer Care Network (MHCCN) and NCORP Activities across the Lifespan | NIH | National Cancer Institute | 2021 to 2025 | $5,149,103 | August 13, 2019 | July 31, 2026 | REMICK, SCOT C | reporter.nih.gov |
| Center for Human Lymphoma Spatiotemporal Atlas (HuLymSTA) | NIH | National Cancer Institute | 2024 to 2025 | $5,130,804 | September 1, 2024 | August 31, 2029 | FAN, RONG | reporter.nih.gov |
| The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression | NIH | National Cancer Institute | 2023 to 2025 | $5,126,849 | September 22, 2022 | August 31, 2027 | CHAN, KEITH SYSON | reporter.nih.gov |
| Precision microRNA medicine in cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,120,362 | August 22, 2019 | July 31, 2026 | SLACK, FRANK J. | reporter.nih.gov |
| Comprehensive Cancer Center Program at Fox Chase | NIH | National Cancer Institute | 2021 to 2025 | $5,119,493 | July 1, 1997 | April 30, 2030 | WIEST, DAVID L. | reporter.nih.gov |
| Precision approaches to refining TP53-associated cancer risk | NIH | National Cancer Institute | 2021 to 2023 | $5,115,949 | September 18, 2019 | August 31, 2025 | GRUBER, STEPHEN B | reporter.nih.gov |
| Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,089,144 | August 16, 2010 | August 31, 2027 | GROGAN, ERIC L | reporter.nih.gov |
| Towards targeting the lymphoma microenvironment | NIH | National Cancer Institute | 2021 to 2025 | $5,082,235 | September 1, 2020 | August 31, 2027 | WENDEL, HANS-GUIDO | reporter.nih.gov |
| Survivorship and Access to care for Latinos to Understand and Address health outcome Differences (SALUD) | NIH | National Cancer Institute | 2023 to 2025 | $5,079,158 | May 10, 2021 | April 30, 2027 | GRAMATGES, MARIA MONICA | reporter.nih.gov |
| One-click Automated 3D Treatment Planning for Radiopharmaceutical Therapy | NIH | National Cancer Institute | 2021 to 2024 | $5,076,565 | April 1, 2018 | June 30, 2025 | WICKRE, PAUL | reporter.nih.gov |
| Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,066,077 | September 1, 2020 | August 31, 2027 | TOKER, ALEX | reporter.nih.gov |
| An atlas of pancreatic tumorigenesis in the context of altered DNA repair occurring in high-risk individuals | NIH | National Cancer Institute | 2024 to 2025 | $5,050,023 | September 1, 2024 | August 31, 2029 | SEARS, ROSALIE C | reporter.nih.gov |
| Columbia University NCI Community Oncology Research Program | NIH | National Cancer Institute | 2021 to 2025 | $5,047,226 | August 1, 2014 | July 31, 2026 | KACHNIC, LISA A. | reporter.nih.gov |
| Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development | NIH | National Cancer Institute | 2021 to 2025 | $5,046,546 | September 1, 2019 | August 31, 2026 | BRUGGE, JOAN SIEFERT | reporter.nih.gov |
| Molecular Mechanism of Mammalian DNA Excision Repair and the Circadian Clock | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $5,040,955 | April 1, 2016 | August 31, 2027 | SANCAR, AZIZ | reporter.nih.gov |
| Identifying the mechanisms of leukemia progression | NIH | National Cancer Institute | 2021 to 2025 | $5,032,279 | September 22, 2021 | August 31, 2028 | CRISPINO, JOHN D | reporter.nih.gov |
| Utility of Random Biopsies in Inflammatory Bowel Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $5,031,513 | July 1, 2024 | June 30, 2029 | LEWIS, JAMES D | reporter.nih.gov |
| Integrating targeted therapy and immunotherapy to break through cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,025,838 | September 1, 2016 | August 31, 2030 | ZHAO, JEAN | reporter.nih.gov |
| Pancreatic Cancer Detection Consortium | NIH | National Cancer Institute | 2021 to 2025 | $5,023,372 | May 1, 2017 | August 31, 2027 | HOLLINGSWORTH, MICHAEL A. | reporter.nih.gov |
| A national Asian American cohort for assessing multi-level determinants in cancer etiology: the ASPIRE Cohort | NIH | National Cancer Institute | 2024 to 2025 | $5,021,641 | July 8, 2024 | June 30, 2029 | GOMEZ, SCARLETT L | reporter.nih.gov |
| Homology-directed repair: BRCA2 and RAD51 paralogs | NIH | National Cancer Institute | 2021 to 2025 | $5,007,139 | August 1, 2020 | July 31, 2027 | JASIN, MARIA | reporter.nih.gov |
| WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC): TASK AREA A AND A2 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,000,825 | September 29, 2025 | September 28, 2026 | JACKSON, REBECCA | reporter.nih.gov |
| Sanford Community Cancer Program of the North Central Plains (NCORP) | NIH | National Cancer Institute | 2021 to 2025 | $4,994,838 | August 12, 2014 | July 31, 2026 | MILANOVICH, SAMUEL J. | reporter.nih.gov |
| Developing a kit-based research use only (RUO) translocation assay for deployment as a lab developed test (LDT) toward changing outcomes for patients with driver-negative tumors | NIH | National Cancer Institute | 2021 to 2024 | $4,982,588 | May 1, 2020 | April 30, 2025 | SELVARAJ, SIDDARTH | reporter.nih.gov |
| CONNECT TASK ORDER 8 | NIH | National Cancer Institute | 2024 | $4,979,276 | September 20, 2024 | September 19, 2025 | FIEGLESON, HEATHER | reporter.nih.gov |
| The role and mechanism of alternative RNA splice variants and gene fusions as drivers of cancer | NIH | National Cancer Institute | 2021 to 2025 | $4,965,167 | September 21, 2021 | August 31, 2028 | HOLLAND, ERIC C. | reporter.nih.gov |
| Differential function and tumor vulnerabilities revealed by RAS membrane trafficking | NIH | National Cancer Institute | 2021 to 2025 | $4,958,727 | September 1, 2020 | August 31, 2027 | PHILIPS, MARK REID | reporter.nih.gov |
| Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis | NIH | National Cancer Institute | 2021 to 2025 | $4,951,939 | August 14, 2015 | July 31, 2029 | ATTARDI, LAURA D | reporter.nih.gov |
| Gastroesophageal junction stem cells as the origin of Barretts esophagus and cancer | NIH | National Cancer Institute | 2022 to 2025 | $4,948,268 | September 1, 2025 | August 31, 2027 | WANG, TIMOTHY CRAGIN | reporter.nih.gov |
| Puerto Rico NCI Community Oncology Research Program (Puerto Rico NCORP) | NIH | National Cancer Institute | 2021 to 2025 | $4,943,161 | August 22, 2014 | July 31, 2026 | SANTOS-REYES, LUIS JAVIER | reporter.nih.gov |
| Reprogramming the Tumor-Immune Interface in Oral Cancer | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $4,940,407 | September 8, 2020 | June 30, 2028 | SUNWOO, JOHN B | reporter.nih.gov |
| Dose-response of aerobic training during total neoadjuvant therapy for locally advanced rectal cancer | NIH | National Cancer Institute | 2022 to 2025 | $4,937,681 | May 6, 2022 | April 30, 2027 | SCOTT, JESSICA | reporter.nih.gov |
| Integrated Networks of Scholars in Global Health Research Training (INSIGHT) | NIH | Fogarty International Center | 2022 to 2025 | $4,936,480 | July 1, 2025 | June 30, 2027 | CHARURAT, MANHATTAN E | reporter.nih.gov |
| Integrating systems immunology with immunometabolism and cancer immunity | NIH | National Cancer Institute | 2021 to 2025 | $4,934,381 | August 1, 2021 | July 31, 2028 | CHI, HONGBO | reporter.nih.gov |
| Targeting the MYC Pathway for the Treatment of Cancer | NIH | National Cancer Institute | 2021 to 2025 | $4,931,456 | September 8, 2020 | August 31, 2027 | FELSHER, DEAN W | reporter.nih.gov |
| Washington University Implementation Science Center for Cancer Control (WU-ISCCC) | NIH | National Cancer Institute | 2021 to 2023 | $4,928,379 | September 18, 2019 | August 31, 2025 | BROWNSON, ROSS C | reporter.nih.gov |
| SCIENTIFIC SUPPORT SERVICES FOR THE NATIONAL CANCER INSTITUTE, DIVISIOIN OF CANCER CONTROL AND POPULATION SCIENCES (DCCPS) | NIH | National Cancer Institute | 2021 to 2022 | $4,921,914 | July 27, 2020 | July 26, 2023 | DAVIS, TERISA | reporter.nih.gov |
| Mechanisms of human papillomavirus entry | NIH | National Cancer Institute | 2021 to 2025 | $4,915,530 | August 17, 2020 | July 31, 2027 | DIMAIO, DANIEL C. | reporter.nih.gov |
| Deciphering the physiological role and interplay between ubiquitination and phosphorylation pathways to guide targeted cancer therapies | NIH | National Cancer Institute | 2021 to 2025 | $4,911,172 | September 1, 2020 | August 31, 2027 | WEI, WENYI | reporter.nih.gov |
| Leveraging Prospective Cancer Epidemiology Cohorts and Novel Methods to Improve Polygenic Risk Scores | NIH | National Cancer Institute | 2021 to 2025 | $4,909,720 | June 16, 2021 | May 31, 2027 | CHEN, FEI | reporter.nih.gov |
| The St. Jude Lifetime Cohort | NIH | National Cancer Institute | 2021 to 2024 | $4,907,509 | July 9, 2015 | June 30, 2025 | HUDSON, MELISSA M | reporter.nih.gov |
| The von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer: Insights into Oxygen Sensing and Treating Cancers Caused by Undruggable Mutations | NIH | National Cancer Institute | 2021 to 2025 | $4,888,860 | September 1, 2016 | August 31, 2030 | KAELIN, WILLIAM G. | reporter.nih.gov |
| Clinical Validation Center for Lung Cancer Early Detection | NIH | National Cancer Institute | 2022 to 2025 | $4,880,009 | September 1, 2022 | August 31, 2027 | HANASH, SAMIR M | reporter.nih.gov |
| Development of Radiation/Nuclear Medical Countermeasures (MCMs) and Biodosimetry Devices | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $4,879,349 | July 1, 2023 | June 30, 2026 | NGUYEN, THERESA | reporter.nih.gov |
| Evaluation of Smoke-Free Housing Policy Impacts on Tobacco Smoke Exposure and Health Outcomes | NIH | National Cancer Institute | 2021 to 2023 | $4,874,420 | December 15, 2017 | November 30, 2023 | THORPE, LORNA | reporter.nih.gov |
| IARC Monographs on the Identification of Carcinogenic Hazards to Humans | NIH | National Cancer Institute | 2021 to 2025 | $4,871,949 | September 1, 1985 | March 31, 2027 | SCHUBAUER-BERIGAN, MARY K. | reporter.nih.gov |
| Genome instability in cancer: telomeres and DNA repair | NIH | National Cancer Institute | 2021 to 2025 | $4,866,062 | September 2, 2016 | August 31, 2030 | DE LANGE, TITIA | reporter.nih.gov |
| Strategically Engineered Multi-Antigen KSHV Vaccine: Integrating Humoral and Cellular Immunity for Effective Protection | NIH | National Cancer Institute | 2025 | $4,857,475 | August 7, 2025 | July 31, 2029 | WU, TING-TING | reporter.nih.gov |
| Trial of Exercise and Lifestyle (TEAL) in Women with Ovarian Cancer | NIH | National Cancer Institute | 2022 to 2025 | $4,851,495 | May 23, 2022 | April 30, 2027 | IRWIN, MELINDA L | reporter.nih.gov |
| Precision Prevention Research Program | NIH | National Cancer Institute | 2021 to 2025 | $4,849,798 | September 1, 2020 | August 31, 2027 | CHAN, ANDREW T | reporter.nih.gov |
| Making cancer precision medicine real: bottlenecks and opportunities | NIH | National Cancer Institute | 2021 to 2025 | $4,848,173 | September 16, 2019 | August 31, 2026 | GOLUB, TODD R. | reporter.nih.gov |
| Predicting Pancreatic Ductal Adenocarcinoma (PDAC) Through Artificial Intelligence Analysis of Pre-Diagnostic CT Images | NIH | National Cancer Institute | 2021 to 2025 | $4,827,743 | September 1, 2021 | August 31, 2026 | LI, DEBIAO | reporter.nih.gov |
| Great Lakes New England Clinical Validation Center | NIH | National Cancer Institute | 2022 to 2025 | $4,820,800 | May 15, 2000 | August 31, 2027 | RICCIARDIELLO, LUIGI | reporter.nih.gov |
| Endosomal mechanisms signaling oral cancer pain | NIH | National Institute of Dental & Craniofacial Research | 2023 | $4,820,611 | September 19, 2023 | August 31, 2026 | SCHMIDT, BRIAN L | reporter.nih.gov |
| Predicting Cancer Cell Response to Endogenous and Exogenous Perturbations at the Single Cell Level | NIH | National Cancer Institute | 2021 to 2025 | $4,812,861 | August 14, 2015 | July 31, 2029 | CALIFANO, ANDREA | reporter.nih.gov |
| From pathogenesis to new therapeutic targets in diffuse large B cell lymphoma | NIH | National Cancer Institute | 2021 to 2025 | $4,812,450 | September 12, 2023 | July 31, 2030 | DALLA-FAVERA, RICCARDO | reporter.nih.gov |
| Phase 1 and 2 Molecular and Clinical Pharmacodynamic Trials ETCTN | NIH | National Cancer Institute | 2023 to 2025 | $4,791,191 | March 28, 2014 | February 28, 2027 | DANILOV, ALEXEY V. | reporter.nih.gov |
| Unmasking the roles of viral glycoproteins in oral transmission of KSHV | NIH | National Cancer Institute | 2021 to 2025 | $4,786,354 | September 1, 2021 | August 31, 2026 | OGEMBO, JAVIER GORDON | reporter.nih.gov |
| Achieving Safe, Comprehensive, Digitally-Enabled Cancer Pain managemeNT” (ASCENT) Clinical Trial | NIH | National Cancer Institute | 2023 to 2025 | $4,784,222 | September 6, 2022 | August 31, 2027 | CHEVILLE, ANDREA LYNNE | reporter.nih.gov |
| NCI NCTN-Network Lead Academic Participating Site at UPMC Hillman Cancer Center | NIH | National Cancer Institute | 2021 to 2025 | $4,775,012 | May 1, 2019 | February 28, 2026 | BRUFSKY, ADAM M | reporter.nih.gov |
| Medical University of South Carolina NCORP Community Site | NIH | National Cancer Institute | 2021 to 2025 | $4,774,115 | August 1, 2014 | July 31, 2026 | MARSHALL, DAVID T. | reporter.nih.gov |
| Determine the molecular and metabolic mechanisms by which A-FABP links dysregulated lipid metabolism-induced obesity/breast cancer risk | NIH | National Cancer Institute | 2022 to 2025 | $4,769,593 | August 12, 2022 | July 31, 2027 | LI, BING | reporter.nih.gov |
| Mechanisms of regulated translation control in cancer and its therapeutic implications | NIH | National Cancer Institute | 2021 to 2025 | $4,757,711 | August 6, 2019 | July 31, 2027 | RUGGERO, DAVIDE | reporter.nih.gov |
| Post genome wide association studies in testicular germ cell tumors | NIH | National Cancer Institute | 2021 to 2024 | $4,743,103 | September 21, 2012 | August 31, 2025 | NATHANSON, KATHERINE L. | reporter.nih.gov |
| Tennessee Valley Cooperative Human Tissue Network | NIH | National Cancer Institute | 2021 to 2025 | $4,741,925 | April 1, 2014 | March 31, 2029 | WASHINGTON, MARY KAY | reporter.nih.gov |
| Mechanistic studies of chromatin modification in transcription regulation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,727,113 | February 14, 2019 | April 30, 2029 | WOLBERGER, CYNTHIA | reporter.nih.gov |
| Investigating molecular and cellular mechanisms of SCLC development to identify novel therapeutic strategies | NIH | National Cancer Institute | 2021 to 2025 | $4,726,654 | September 9, 2019 | August 31, 2026 | SAGE, JULIEN | reporter.nih.gov |
| Proteogenomic studies to understand mechanisms and drivers of resistance to immunotherapies | NIH | National Cancer Institute | 2022 to 2025 | $4,722,849 | June 16, 2022 | May 31, 2027 | PAULOVICH, AMANDA G | reporter.nih.gov |
| Metabolic Influences on Complex Tumor Neighborhoods | NIH | National Cancer Institute | 2021 to 2025 | $4,722,150 | August 1, 2017 | July 31, 2030 | SIMON, M. CELESTE | reporter.nih.gov |
| Tissue mechanics reprograms the tissue to malignancy and metastasis | NIH | National Cancer Institute | 2021 to 2025 | $4,718,149 | September 1, 2020 | August 31, 2027 | WEAVER, VALERIE MARIE | reporter.nih.gov |
| Technical Information Research Resources for Cancer Preventive Agent Development | NIH | National Cancer Institute | 2021 to 2022 | $4,707,513 | September 30, 2018 | September 29, 2023 | SIGMAN, CAROLINE | reporter.nih.gov |
| NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1 (funded extension) | NIH | National Cancer Institute | 2021 to 2025 | $4,704,575 | April 12, 2019 | February 28, 2026 | BOUGHEY, JUDY CAROLINE | reporter.nih.gov |
| Human metabolic variation as a window into cancer initiation and progression | NIH | National Cancer Institute | 2021 to 2025 | $4,687,860 | September 4, 2017 | August 31, 2030 | DEBERARDINIS, RALPH J | reporter.nih.gov |
| Comparative Modeling of Lung Cancer Prevention, Early Detection and Treatment Interventions | NIH | National Cancer Institute | 2022 to 2025 | $4,678,848 | December 3, 2022 | August 31, 2026 | MEZA, RAFAEL | reporter.nih.gov |
| CIRI Oncology Research Alliance | NIH | National Cancer Institute | 2021 to 2025 | $4,657,240 | August 1, 2014 | July 31, 2026 | SIDDIQUE, SHAHZAD | reporter.nih.gov |
| Live-cell Activity Architecture in Cancer | NIH | National Cancer Institute | 2021 to 2025 | $4,655,641 | August 1, 2015 | July 31, 2029 | ZHANG, JIN | reporter.nih.gov |
| Effects of Time-restricted Eating versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers among Adults with Obesity | NIH | National Cancer Institute | 2021 to 2025 | $4,635,563 | September 1, 2021 | August 31, 2027 | TUSSING-HUMPHREYS, LISA | reporter.nih.gov |
| Mutations of Chromatin and its Modifying Machineries in Malignancies | NIH | National Cancer Institute | 2021 to 2025 | $4,635,274 | August 13, 2015 | August 31, 2029 | SHILATIFARD, ALI | reporter.nih.gov |
| Bcl-2 and Mcl-1 inhibition for induction of hematopoietic chimerism and renal allograft tolerance without myelosuppression in nonhuman primates | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,613,595 | June 3, 2022 | May 31, 2027 | KAWAI, TATSUO | reporter.nih.gov |
| Decoding and Targeting the PI3K-mTOR Signaling Network in Cancer | NIH | National Cancer Institute | 2021 to 2025 | $4,612,435 | August 1, 2022 | July 31, 2029 | MANNING, BRENDAN D. | reporter.nih.gov |
| Early to Late Events in Colorectal Neoplasia: Basic Biology to Clinical Implementation | NIH | National Cancer Institute | 2021 to 2025 | $4,608,771 | April 1, 2017 | July 31, 2031 | COFFEY, ROBERT J. | reporter.nih.gov |
| Proteogenomic characterization of early and late resistance mechanisms in acute myeloid leukemia | NIH | National Cancer Institute | 2022 to 2025 | $4,603,890 | June 15, 2022 | May 31, 2027 | TYNER, JEFFREY WALLACE | reporter.nih.gov |
| Defining Drivers of HPV-associated Carcinogenesis | NIH | National Cancer Institute | 2021 to 2025 | $4,601,591 | August 1, 2017 | July 31, 2031 | LAMBERT, PAUL F. | reporter.nih.gov |
| NCORP: Colorado Cancer Research Program | NIH | National Cancer Institute | 2021 to 2025 | $4,600,668 | August 1, 2014 | July 31, 2026 | DIBELLA MD, NICHOLAS | reporter.nih.gov |
| A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform | NIH | National Center for Advancing Translational Sciences | 2021 to 2024 | $4,598,428 | July 1, 2021 | April 30, 2026 | HINGTGEN, SHAWN | reporter.nih.gov |
| Chemical Approaches to Modulate PAX3-FOXO1 in Fusion-Positive Alveolar Rhabdomyosarcoma | NIH | National Cancer Institute | 2024 to 2025 | $4,597,865 | September 6, 2024 | August 31, 2029 | KOEHLER, ANGELA NICOLE | reporter.nih.gov |
| Molecular and Cellular Regulation of Pre-Leukemic Stem Cells and their Therapeutic Targeting | NIH | National Cancer Institute | 2021 to 2025 | $4,594,192 | September 1, 2021 | August 31, 2028 | STEIDL, ULRICH | reporter.nih.gov |
| Molecular Pathogenesis of Acute Myeloid Leukemia | NIH | National Cancer Institute | 2021 to 2025 | $4,591,274 | August 13, 2015 | June 30, 2029 | LEY, TIMOTHY J. | reporter.nih.gov |
| Towards a quantitative understanding of tumor evolution | NIH | National Cancer Institute | 2021 to 2025 | $4,585,388 | August 1, 2021 | July 31, 2028 | RABADAN, RAUL | reporter.nih.gov |
| Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research | NIH | National Cancer Institute | 2021 to 2025 | $4,582,548 | August 5, 2015 | July 31, 2029 | LIN, XIHONG | reporter.nih.gov |
| Next Generation Cancer Immunotherapies to Defeat Melanoma | NIH | National Cancer Institute | 2021 to 2025 | $4,577,719 | September 9, 2015 | August 31, 2029 | RIBAS, ANTONI | reporter.nih.gov |
| Tissue factor-dependent coagulation in thrombosis and immune responses | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,577,076 | February 1, 2021 | January 31, 2028 | MACKMAN, NIGEL | reporter.nih.gov |
| Inducing Proximity: An Emerging Paradigm for New Therapeutic Modalities | NIH | National Cancer Institute | 2021 to 2025 | $4,561,169 | September 9, 2015 | August 31, 2029 | CREWS, CRAIG M | reporter.nih.gov |
| Mechanisms underlying gastric intestinal metaplasia and carcinogenesis | NIH | National Cancer Institute | 2022 to 2025 | $4,560,310 | September 20, 2022 | August 31, 2027 | RUSTGI, ANIL K | reporter.nih.gov |
| Targeting transcriptional addiction in fusion-driven sarcoma | NIH | National Cancer Institute | 2024 to 2025 | $4,553,009 | July 8, 2024 | June 30, 2029 | MCFADDEN, DAVID GLENN | reporter.nih.gov |
| THE CANCER EPITOPE DATABASE AND ANALYSIS RESOURCE | NIH | National Cancer Institute | 2021 to 2025 | $4,550,196 | May 5, 2021 | April 30, 2027 | SETTE, ALESSANDRO | reporter.nih.gov |
| PULSE - BRIDGE-C2: DeveloPing a Pragmatic GUide to ImpLementing Social RiSk AssistancE | NIH | National Cancer Institute | 2021 to 2023 | $4,548,252 | September 19, 2019 | August 31, 2024 | HUGUET, NATHALIE | reporter.nih.gov |
| Therapeutic Targeting of Human AML Stem Cells | NIH | National Cancer Institute | 2021 to 2025 | $4,546,001 | September 8, 2020 | August 31, 2027 | JORDAN, CRAIG T. | reporter.nih.gov |
| Comprehensive molecular characterization of endometrial cancer, etiologic heterogeneity, and racial disparities | NIH | National Cancer Institute | 2021 to 2025 | $4,544,010 | February 5, 2021 | January 31, 2027 | DE VIVO, IMMACULATA | reporter.nih.gov |
| Mechanisms of DNA Homology-directed Genome Repair and Tumor Suppression | NIH | National Cancer Institute | 2021 to 2025 | $4,541,517 | September 9, 2019 | August 31, 2026 | SUNG, PATRICK | reporter.nih.gov |
| Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy | NIH | National Cancer Institute | 2021 to 2025 | $4,541,273 | September 17, 2019 | August 31, 2026 | TING, JENNY P | reporter.nih.gov |
| Center on Probes for Molecular Mechanotechnology | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $4,539,606 | August 10, 2023 | July 31, 2028 | SALAITA, KHALID S. | reporter.nih.gov |
| Ovarian Cancer Survival in African-American Women | NIH | National Cancer Institute | 2021 to 2024 | $4,527,423 | July 1, 2020 | June 30, 2026 | SCHILDKRAUT, JOELLEN M. | reporter.nih.gov |
| Behavioral and Psychosocial Effects on Study Outcomes in End-Stage Cancer Treatment (BEST End-Stage Cancer Study) | NIH | National Cancer Institute | 2021 to 2025 | $4,525,183 | September 1, 2015 | July 31, 2029 | PRIGERSON, HOLLY GWEN | reporter.nih.gov |
| Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming | NIH | National Cancer Institute | 2021 to 2025 | $4,524,524 | June 1, 2025 | July 31, 2026 | SCHALLENKAMP, JOHN M. | reporter.nih.gov |
| DEVELOPMENT, MAINTENANCE, AND PROMOTION OF NCI SPONSORED BEHAVIORAL AND MOBILE HEALTH INITIATIVES. | NIH | National Cancer Institute | 2021 to 2024 | $4,522,410 | September 15, 2021 | September 14, 2025 | SCHWARZ, MARY | reporter.nih.gov |
| Regulatory T cells and the tumor microenvironment | NIH | National Cancer Institute | 2021 to 2025 | $4,516,979 | August 1, 2021 | July 31, 2028 | VIGNALI, DARIO AA | reporter.nih.gov |
| Texas Pediatric NCORP | NIH | National Cancer Institute | 2021 to 2025 | $4,510,206 | August 1, 2014 | July 31, 2026 | LANGEVIN, ANNE-MARIE R. | reporter.nih.gov |
| Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health Study | NIH | National Cancer Institute | 2021 to 2023 | $4,508,718 | July 22, 2014 | June 30, 2025 | ELIASSEN, A. HEATHER | reporter.nih.gov |
| Mentoring Translational Cancer Research in Oklahoma | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $4,499,760 | September 5, 2012 | June 30, 2024 | DHANASEKARAN, DANNY N. | reporter.nih.gov |
| TeleHealth Resistance exercise Intervention to preserve dose intensity and Vitality in Elder breast cancer patients (THRIVE) | NIH | National Cancer Institute | 2022 to 2025 | $4,496,377 | December 19, 2022 | March 31, 2027 | SCHMITZ, KATHRYN H. | reporter.nih.gov |
| Determinants of the racial/ethnic disparity in MGUS risk: An epidemiologic study in 4 cohorts | NIH | National Cancer Institute | 2021 to 2025 | $4,479,852 | September 20, 2021 | August 31, 2026 | COZEN, WENDY | reporter.nih.gov |
| Support for the Central Data Collection Center (CDCC) | NIH | National Cancer Institute | 2021 to 2025 | $4,460,745 | February 27, 2021 | February 26, 2025 | MATHEW, SUNITHA | reporter.nih.gov |
| Unified and fair multimodal representation learning for autoimmune diseases | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $4,435,452 | September 16, 2024 | September 15, 2026 | SHEIKH, SAIRA Z | reporter.nih.gov |
| FY22 COMMUNICATION SUPPORT FOR DCCPS | NIH | National Cancer Institute | 2022 | $4,427,444 | March 1, 2022 | February 28, 2023 | TAYLOR, GEAGHAN | reporter.nih.gov |
| Leveraging the National Cancer Institute’s Cancer Center Cessation Initiative (C3I) Program to Evaluate and Transform Smoking Cessation Treatment in Cancer Care | NIH | National Cancer Institute | 2021 to 2025 | $4,423,867 | August 1, 2015 | August 31, 2029 | FIORE, MICHAEL C | reporter.nih.gov |
| Modeling Precision Interventions for Prostate Cancer Control | NIH | National Cancer Institute | 2021 to 2025 | $4,423,369 | June 15, 2025 | August 31, 2026 | ETZIONI, RUTH D | reporter.nih.gov |
| The VITamin D and OmegA-3 TriaL (VITAL): Post-Intervention Follow-Up | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $4,414,294 | September 29, 2009 | December 31, 2026 | MANSON, JOANN ELISABETH | reporter.nih.gov |
| U24-Uncovering the Shared Genetic Origins of Childhood Cancer and Structural Birth Defects Through Enhanced Data Integration and Analysis with the CFDE Data Distillery Knowledge Graph. | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $4,408,884 | September 19, 2024 | August 31, 2027 | TAYLOR, DEANNE MARIE | reporter.nih.gov |
| Pediatric Early Phase Clinical Trials Network (PEP-CTN) Transfer Application | NIH | National Cancer Institute | 2025 | $4,394,441 | August 1, 2025 | July 31, 2029 | FOX, ELIZABETH | reporter.nih.gov |
| PDXNet Data Commons and Coordinating Center | NIH | National Cancer Institute | 2021 to 2025 | $4,390,710 | September 25, 2017 | August 31, 2028 | CHUANG, JEFFREY HSU-MIN | reporter.nih.gov |
| The Integrative Genomics Viewer (IGV) for Cancer Research | NIH | National Cancer Institute | 2021 to 2025 | $4,380,809 | September 7, 2021 | August 31, 2027 | MESIROV, JILL P. | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| University of TX MD Anderson Can CTR | Houston, TX | 529 | $714.8 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 434 | $661.2 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 422 | $584.7 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 360 | $526 million | 0 | $0 |
| Dana-Farber Cancer Inst | Boston, MA | 334 | $498.3 million | 0 | $0 |
| Stanford University | Stanford, CA | 396 | $491.4 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 410 | $486.5 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 400 | $457.4 million | 0 | $0 |
| Washington University | Saint Louis, MO | 337 | $433 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 355 | $414.7 million | 0 | $0 |
| Fred Hutchinson Cancer Center | Seattle, WA | 212 | $405.6 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 272 | $383.9 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 303 | $382.2 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 202 | $379.9 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 320 | $371 million | 0 | $0 |
| Yale University | New Haven, CT | 268 | $337.8 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 256 | $318.2 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 231 | $312.5 million | 0 | $0 |
| Duke University | Durham, NC | 288 | $309.5 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 153 | $309.4 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 199 | $306.1 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 255 | $292.6 million | 0 | $0 |
| Ohio State University | Columbus, OH | 240 | $284 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 215 | $277.7 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 211 | $276.7 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 139 | $268.7 million | 0 | $0 |
| Beckman Research Institute/city of Hope | Duarte, CA | 175 | $263.4 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 191 | $263.2 million | 0 | $0 |
| Emory University | Atlanta, GA | 237 | $257.4 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 191 | $251.3 million | 0 | $0 |
| ST. Jude Children's Research Hospital | Memphis, TN | 126 | $251.1 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 204 | $246.8 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 133 | $244.5 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 255 | $242 million | 0 | $0 |
| H. Lee Moffitt Cancer CTR & Res Inst | Tampa, FL | 177 | $230.3 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 158 | $225.8 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 213 | $220.3 million | 0 | $0 |
| Public Health Institute | Oakland, CA | 8 | $209.9 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 167 | $207.8 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 187 | $203.2 million | 0 | $0 |
| University of Washington | Seattle, WA | 143 | $199.3 million | 0 | $0 |
| University of Chicago | Chicago, IL | 178 | $194.9 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 147 | $183.5 million | 0 | $0 |
| Roswell Park Cancer Institute Corp | Buffalo, NY | 122 | $171 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 54 | $163 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 116 | $150.6 million | 0 | $0 |
| University of Florida | Gainesville, FL | 149 | $147.9 million | 0 | $0 |
| University of California at Davis | Davis, CA | 129 | $146.7 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 84 | $142.8 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 96 | $141.3 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 115 | $138.5 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 92 | $137.1 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 116 | $133.8 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 109 | $133.4 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 113 | $128.9 million | 0 | $0 |
| Westat, Inc. | Bethesda, MD | 13 | $126.7 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 106 | $123.9 million | 0 | $0 |
| Kaiser Foundation Research Institute | Oakland, CA | 48 | $123.5 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 100 | $122.5 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 79 | $122 million | 0 | $0 |
| Leidos Biomedical Research, Inc. | Frederick, MD | 2 | $119.7 million | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 115 | $118.9 million | 0 | $0 |
| Ecog-Acrin Medical Research Foundation | Philadelphia, PA | 3 | $118.8 million | 0 | $0 |
| Georgetown University | Washington, DC | 84 | $118.3 million | 0 | $0 |
| Information Management Services, Inc. | Calverton, MD | 8 | $117.8 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 96 | $117.7 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 100 | $116.3 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 65 | $113.4 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 100 | $110.4 million | 0 | $0 |
| University of Oklahoma HLTH Sciences CTR | Oklahoma City, OK | 64 | $107.1 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 107 | $103.5 million | 0 | $0 |
| Dartmouth College | Hanover, NH | 66 | $102.7 million | 0 | $0 |
| Thomas Jefferson University | Philadelphia, PA | 81 | $101.5 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 85 | $100.7 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 76 | $100.6 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 59 | $98.8 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 45 | $98.4 million | 0 | $0 |
| University of Rochester | Rochester, NY | 75 | $97.9 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 89 | $90.8 million | 0 | $0 |
| Research Inst Nationwide Children's Hosp | Columbus, OH | 25 | $89.5 million | 0 | $0 |
| University of Hawaii | Honolulu, HI | 32 | $87.5 million | 0 | $0 |
| Ctis, Inc. | Rockville, MD | 1 | $86.9 million | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 85 | $85 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 93 | $84.1 million | 0 | $0 |
| Wistar Institute | Philadelphia, PA | 54 | $78.8 million | 0 | $0 |
| The Emmes Company, LLC | Rockville, MD | 4 | $77.8 million | 0 | $0 |
| Research Inst of Fox Chase Can CTR | Philadelphia, PA | 70 | $76.8 million | 0 | $0 |
| NRG Oncology Foundation, Inc. | Philadelphia, PA | 2 | $76.7 million | 0 | $0 |
| George Washington University | Washington, DC | 49 | $76.5 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 101 | $75.2 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 55 | $73.8 million | 0 | $0 |
| Univ of Arkansas for Med Scis | Little Rock, AR | 45 | $73.1 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 77 | $71.4 million | 0 | $0 |
| Cold Spring Harbor Laboratory | Cold Spring Harbor, NY | 56 | $68.9 million | 0 | $0 |
| Methodist Hospital Research Institute | Houston, TX | 54 | $68.2 million | 0 | $0 |
| Sanford Burnham Prebys Medical Discovery Institute | La Jolla, CA | 43 | $67.1 million | 0 | $0 |
| University of New Mexico Health Scis CTR | Albuquerque, NM | 44 | $66.8 million | 0 | $0 |
| Fred Hutchinson Cancer Research Center | Seattle, WA | 133 | $64.6 million | 0 | $0 |
| Wayne State University | Detroit, MI | 51 | $61.5 million | 0 | $0 |
| Salk Institute for Biological Studies | La Jolla, CA | 38 | $61.4 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 9,152 | $5,485,376,380 | 0 | $0 |
| 2024 | 9,871 | $5,292,305,000 | 0 | $0 |
| 2023 | 9,933 | $5,317,800,487 | 0 | $0 |
| 2022 | 9,835 | $5,066,604,302 | 0 | $0 |
| 2021 | 9,562 | $4,806,166,382 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.